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ABSTRACT 
Objective 
 
The objective of the proposed study was to investigate tissue changes induced by 
orthodontic forces at both tension and compression sites, with a view to better 
understanding the biological processes that lead to differing rates of tooth movement 
and adverse events. 
 
 
Methods 
 
Gingival Crevicular Fluid (GCF), was collected from mesiobuccal and distopalatal 
locations on maxillary canine and second molar teeth using Periopaper! strips for 30s 
from volunteers (n=21).  Samples were taken at: baseline, before appliance placement 
and tooth extraction (B); three months into orthodontic treatment (T1); at four hours 
(T2); 1 week (T3); and 6 weeks (T4) after a distalising force had been applied to the 
maxillary canine teeth.  At each time point detailed periodontal health measures and 
plaque scores were recorded, as well as impressions of the teeth.  Study casts were 
used to measure canine movement.  GCF volumes were recorded and proteins eluted 
into sterile water and stored at -80°C. Cytokines (GM-CSF, IFN", IL-1#, IL-2, IL-4, 
IL-5, IL-6, IL-8, IL-10 and TNF$), tissue (MMP-9, TIMP-1 and 2) and bone 
metabolism (RANKL and OPG) biomarkers were measured using muliplex protein 
arrays on a Luminex 200! machine.  
 
 
Data analysis 
 
Data were analysed using a Prism computer softwear programme. 
 
Results 
 
Tension sites at the maxillary canines showed increases in IL-1!, IL-8, TNF", MMP-
9 and TIMPs 1 and 2 across time points T2-T4, whereas the compression sites for 
these teeth showed increases in IL-1! and IL-8 only at T2, MMP-9 at T3 and T4 and 
RANKL at T4.  GCF volume increased from T2 to T4 but plaque scores or bleeding 
on probing did not increase over this time.  Increases in the levels of biomarkers were 
more consistently detected at sites of tension than of compression. Other biomarkers 
were below assay detection limits. 
 
Conclusions 
 
There were significant changes in the profile of several biomarkers at the various time 
points.  These were consistant with tissue remodelling.  Although differences were 
seen between tension and compression sites, none of these were statistically 
significant.  
 
 Increases in TNF", GM-CSF, IL-1! and IL-8 correlated with the rate of tooth 
movement.  MMP-9, TIMP-1 and TIMP-2 correlated with rate of movement 4 hours 
after application of a distalising force. 
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1.1   Introduction 
Application of an appropriate force to a tooth results in tooth movement.  Orthodontic 
therapy is based on this principle and relies upon remodelling of the periodontal 
ligament, gingival soft tissue and alveolar bone (periodontium) in order to allow tooth 
movement, during which tissue is removed ahead of the tooth and deposited behind. 
 
The periodontium consists largely of connective tissue.  For optimal rates of tooth 
movement the biological reaction generated in response to orthodontic force must be  
optimised to prevent iatrogenic and degenerative changes including resorption of root 
dentine. 
 
Many factors influence the course of orthodontic treatment, including patient 
compliance and individual biological responses to the application of orthodontic force 
(Reitan, 1954).  Gingival crevicular fluid (GCF) is a serum transudate.  During its 
passage from the vascular system, through the periodontal tissues and into the 
gingival crevice, various substances (microbial or host-origin) are incorporated which 
reflect the biology and physiology of the local tissues (Last et al., 1988).  Studies have 
used gingival crevicular fluid to assess changes within the periodontium and have 
related those changes to tooth movement.  However the majority of studies have 
assessed individual biomarkers, which are representative of only a single biological 
pathway.  Waddington and Embery (2001) concluded that “It may well be that a 
package of biomarkers may provide a more complete answer”. 
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Protein/cytokine arrays provide a contemporary technology necessary to 
simultaneously profile different pathways, including inflammatory cytokine (e.g. IL-
1, TNF!) pathways and bone metabolic pathways involving matrix metalloproteinases 
(MMPs) and their inhibitors (TIMPs).  MMPs are zinc-dependent proteases with the 
capacity to degrade extracellular matrix proteins (e.g. collagen, elastin). MMP-2 and 9 
and TIMP-1 and 2 are thought to be important in bone metabolism (NIH, 2006).  In 
the present study panels of cytokines, tissue and bone metabolites were quantified in 
GCF using protein arrays, to profile the biological response to orthodontic force. 
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1.2   Background 
1.2.1 Remodelling of the periodontium 
Orthodontic tooth movement requires remodelling of the periodontal tissues, with 
tissue removal ahead of the tooth and the deposition and re-establishment of tissue 
architecture behind.  Orthodontic therapy is dependent on this remodelling. 
 
When similar force systems are set up in different individuals the rate of tooth 
movement varies due to differences in bone density, connective tissues, and cellular 
responses within the periodontal ligament.  
 
Whilst the response of individual teeth to orthodontic force is important, there is little 
research available to enable the orthodontist to guage ideal force levels and thus 
achieve optimal rates of tooth movement. It is known that subjects vary in their 
responses to orthodontic forces irrespective of age (Reitan, 1954), but it is not known 
how to predict this. 
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1.2.2   Bone remodelling 
Bone structure is intimately related to function; an outer layer of dense cortical bone 
surrounds a core of less dense trabecular bone.  The cells predominantly responsible 
for the turnover of bone matrix are osteoblasts and osteoclasts. 
 
1.2.2.1    The bone remodelling cycle 
The initial steps of bone remodelling involve the differentiation and activation of 
osteoclast precursors to form osteoclasts, which then begin the process of bone 
resorption.  Resorption is followed by bone formation, the number of sites entering a 
phase of bone formation combined with the rate of resorption will determine overall 
turnover (Ericksen et al., 1986; Charles et al., 1987). 
 
As mentioned previously, the process of bone resorption and formation are 
interlinked.  Details of the linking mechanisms are unknown, although transforming 
growth factor (TGF)-ß, insulin-like growth factor (IGF) and plasminogen activators 
have all been suggested (Martin and Ng, 1994). 
 
The osteoclast is the primary resorbing cell.  Initially there is recruitment and 
dissemination of osteoclast progenitors.  Such cells are haemopoietic in origin and are 
related to the monocyte-macrophage lineage.  Differentiation into osteoclasts is 
thought to involve cell-to-cell interaction with osteoblast stromal cells (Suda et al., 
1996). 
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The bone surface is prepared by the removal of the surface un-mineralised osteoid by 
the osteoblasts which line it and produce many proteolytic enzymes including MMPs, 
collagenase and gelatinase.  Osteoclasts recognise extracellular bone matrix proteins 
such as osteopontin through cell surface integrin adhesion molecules. 
 
The osteoclast then becomes activated at the surface of the mineralised bone.  Such 
activation is thought to be mediated through the osteoblast via local factors or cell-to-
cell contacts (Fuller et al., 1991). 
 
Osteoclasts resorb the bone surface by producing hydrogen ions, which change the pH 
balance and dissolve the inorganic elements.  Proteolytic enzymes then degrade the 
organic components.  The organic matrix is composed mainly of collagen type I (90% 
of the protein in bone) and is degraded by two main types of enzyme, the lysosomal 
cysteine proteinases cathepsin B, L, and K together with the matrix 
metalloproteinases; collagenase and gelatinase B. 
 
The cessation of osteoclast activity results from apoptosis (programmed cell death), 
which suggests that the regulation of osteoclast life span may be another important 
determinant of bone metabolism. 
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1.2.2.2  Bone deposition 
Around nine days following the onset of resorption, when the osteoclast has eroded 
the bone surface to a maximum depth, a reversal process begins.  Osteoclastic activity 
is reduced by apoptosis.  Increased calcium levels within the sub-cellular space inhibit 
further resorption whilst substances released from the bone matrix during resorption 
initiate osteoclast deactivation. 
 
As with resorption, bone deposition is the end point of a complex cascade of events 
involving proliferation of primitive mesenchymal cells, formation of preosteoblasts, 
matrix formation and mineralization.  Osteoblasts converge onto the base of the 
resorption cavity to form osteoid.  Cells are attracted towards the resorptive defect by 
local factors including Transforming Growth Factor " (TGF-") and the exposed type I 
collagen.  Local proliferation of osteoblast precursors is influenced by TGF-" 
,Insulin-Like Growth Factor (IGF) I and II, Fibroblast Growth Factor (FGF) and 
Platelet Derived Growth Factor (PDGF). 
 
Differentiation of cells into mature osteoid-producing cells is mediated by IGF-I and 
BMP-2.  Osteoid begins to mineralise 13 days later at a rate of approximately 1µm 
per day (Ericksen et al., 1986).  Bone formation continues until the cavity is filled, 
over 120-180 days.   
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1.2.3 Theory of tooth movement. 
The first theory was described by Burstone (1962) who suggested that there were 3 
phases of tooth movement: an initial phase, a lag phase, and a post lag phase.  
 
In the initial phase there is rapid movement after the application of force largely 
attributable to displacement of the tooth in its socket.  After the initial phase, there is a 
lag period due to hyalinization in areas of compression. No further tooth movement 
occurs until cells complete the removal of necrotic tissue. The third phase of tooth 
movement follows the lag period, during which the rate of movement gradually or 
suddenly increases (Burstone, 1962). 
 
Other studies have proposed a time/ displacement model for tooth movement (Pilon et 
al., 1996, Vas Leeuwen et al., 1999). These studies divided the curve representing  
tooth movement into 4 phases. The first phase lasts 24 hours to 2 days and represents 
initial movement of the tooth inside its bony socket (Burstone’s initial phase). This is 
followed by a second phase, when tooth movement stops for 20-30 days (Burstone’s 
lag phase). After removal of necrotic tissue tooth movement is accelerated in the third 
phase (Burstone’s post lag phase) and continues into the fourth phase.  
 
Neither hypothesis provides conclusive evidence to explain the detailed nature of the 
biological mechanism of tooth movement.  Other studies in the 20
th
 century and the 
early 21st century demonstrated that many cellular and tissue reactions start in the 
initial phase of tooth movement, immediately after force application. Because of the 
compression and stretch of fibres and cells in the PDL, the complex process of 
recruitment of osteoclast and osteoblast progenitors, as well as extravasation and 
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chemoattraction of inflammatory cells begins. Blood flow disruption due to distortion 
of the PDL fibres leads to the development of hyalinized areas and the arrest of tooth 
movement, which can last 4-20 days. Only removal of necrotic tissue and bone 
resorption from adjacent marrow spaces (indirect resorption) and from the direction of 
the viable PDL (undermining resorption) allow the resumption of tooth movement. 
This comprehensive process requires the recruitment of phagocytic cells such as 
macrophages, foreign body giant cells, and osteoclasts from adjacent undamaged 
areas of the PDL and alveolar bone marrow cavities. These cells remove necrotic 
tissues from compressed PDL sites and adjacent alveolar bone. In areas of PDL 
tension, quiescent osteoblasts are enlarged and start producing new osteoid. 
Osteoblast progenitors are recruited from the population of fibroblast-like cells 
(pericytes) around PDL capillaries, which proliferate and migrate toward the alveolar 
bone surface, along the stretched Sharpey’s fibers. Simultaneously, PDL fibroblasts in 
tension zones begin multiplying and remodelling their surrounding matrix.  
 
The third and fourth phases of orthodontic tooth movement, also known as the 
acceleration and linear phases, respectively, start about 40 days after initial force 
application. The pressure sides of teeth exhibit collagen fibres without proper 
orientation. Here, irregular bone surfaces are found, indicating direct or frontal 
resorption. 
 
The development and removal of necrotic tissue is a continuous process during tooth 
displacement, rather than a single event (von Böhl et al.,2004 a and b).  This 
conclusion is supported by one of Melsen’s hypotheses that “indirect bone resorption 
at the pressure side is not a reaction to force but an attempt to remove ischemic bone 
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lying adjacent to the hyalinised tissue. The subsequent direct bone resorption could be 
considered part of the remodelling process.”The tension sides in the third and fourth 
phases clearly show bone deposition, as evidenced by alkaline phosphatase positive 
osteoblastic cells” (Melsen, 1999).  
 
Teeth subjected to high forces show hyalinization more often than teeth experiencing 
light forces. Thus, development of hyalinization zones has a definite relationship to 
the force magnitude, but it was found to have no relationship to the rate of tooth 
movement. Once tooth movement has started after the second (arrest) phase, bone 
remodelling takes place at a certain rate, independent of force magnitude (Von Bohl 
et al., 2004). These findings agree with those of Owman-Moll et al. (1996) and Van 
Leeuwen et al. (1999), who also reported the location of hyalinization was found 
mostly buccal or lingual to the mesio-distal plane.   Studies have also shown that a lag 
period exists between an abrupt change in mechanical loading and the attainment of 
maximal response (Jaworski et al., 1980). 
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1.2.4 Remodelling of the periodontal ligament 
1.2.4.1   Areas of compression 
Compression of the periodontium produces narrowing of the periodontal ligament and 
vascular restriction.  This can lead to ischaemia, necrosis and vessel degeneration.  A 
high enough force can lead to hyalinisation or sterile necrosis.  However if the 
periodontal ligament can be maintained despite the reduction in blood supply, cellular 
activity increases with differentiation of monocytes into fibroblasts and osteoclasts.  
These two cell types are responsible for remodelling of the soft and hard tissues. The 
breakdown products of tissue turnover may be detected in GCF (Last et al., 1988). 
 
Areas of hyalinisation are devoid of blood supply, so that the host is unable to recruit 
a cellular inflammatory response and resorption cannot occur.  However, orthodontic 
force is distributed unevenly within the periodontal ligament, there are adjacent areas 
of normal periodontium and these areas contribute to remodelling of the hyalinised 
areas as osteocytes and vascular elements penetrate hyalinised tissue, whilst the 
alveolar bone in this area is removed by underlying resorption. (Rygh et al., 1973). 
 
Removal of bone from areas of compression is not a simple or continuous process.  
Following application of orthodontic force, small bony changes occur within the first 
three days, followed by a wave of resorption lasting one week, which is then followed 
by bony deposition (King et al., 1992).  Bone remodelling can continue for some time 
even after the orthodontic force has been removed (King et al., 1992).  In order to 
investigate host response to orthodontic force, a period of time should separate force 
application and assessment of the response to that force.   
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Osteoclasts within the resorptive area arise from two sources, some are derived 
locally and arrive within hours of the initiation of orthodontic force (Reitan, 1951), 
some arrive two days later and arise from the haematogenous cell population (Roberts 
and Ferguson, 1989).  Although osteoclasts are the primary resorptive cells, 
osteoblasts possess receptors for the chemical signal of resorption namely; 
parathyroid hormone, eicosanoids (e.g. Prostaglandin E2) and various cytokines 
(Meghji, 1992).  
Bone resorption is undertaken by organic acids, lysosomal enzymes, matrix 
metalloproteinases (MMPs) and serine proteases (Keeling et al., 1993). Thus the 
inorganic components are dissolved and the organic matrix digested in a process 
called frontal resorption. 
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1.2.4.2 Areas of tension 
Fibres of the periodontal ligament stretch in areas of tension.  This is associated with 
vascular dilatation and an increase in local vascular activity (Rygh et al., 1986).  In 
areas under tension the volume of collagen reduces in the first three days whilst 
vascularisation increases (Crumley, 1964).  Mechanical stress leads to the production 
of collagenase enzymes (MMPs) produced by macrophages and fibroblasts (Sandy, 
1992).  Collagen fibres within the periodontal ligament exist in coiled forms. When 
tooth movement exceeds the intrinsic fibre length, new fibres must be synthesised and 
incorporated into the ligament proper.     
 
Osteoblasts are generated from progenitor cells locally within the periodontium 
(Roberts and Chase, 1981).  Following vascular dilatation, an area of intense 
increased vascular activity develops.  Osteoblasts form sheets of densely packed cells 
on the bone surface and secrete the extracellular organic matrix of bone; components 
include type I collagen, osteocalcin, osteoponin and osteonectins. Cytokines, 
proteoglycans and growth regulating factors are also released.  Osteoid deposition 
begins some two days following the application of orthodontic force and shortly 
afterwards mineralisation occurs within the deeper osteoid layers, although the 
surface layers remain un-calcified (Rygh et al., 1986). 
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1.2.5   Control of orthodontic tooth movement 
There is still much to be discovered about the biological basis of orthodontics.  Four 
theories have been proposed: 
o The biomechanical theory 
o The pressure/tension theory 
o The piezoelectric theory 
o The hydrodynamic theory 
The hydrodynamic theory will not be discussed in this thesis. 
1.2.5.1  Biomechanical theory 
The biomechanical theory is based on mechanical distortion of cell membranes and 
resultant activation of phospholipase A2 (Sandy et al., 1993).  Phospholipase A2 
initiates arachidonic acid metabolism, which in turn activates the lipoxygenase 
pathway (leukotrienes and HETE) and the cyclo-oxygenase pathway (prostoglandins). 
There is clinical evidence that both leukotrienes and prostoglandins are linked to tooth 
movement (Yamasaki et al., 1989; Mohammed et al., 1989). Prostaglandins feedback 
to G protein coupled receptors and stimulate second messenger cascades, resulting in 
a cellular response that causes bone removal at compression sites and deposition at 
tension sites.  
 
Chapter 1  Introduction and Background 
 15 
1.2.5.2   Pressure-tension theory 
The pressure-tension theory relates changes in periodontal ligament blood flow, 
following the application of pressure, to the release of chemical messengers that effect 
cellular responses.  Tension and compression within the periodontal ligament result in 
a gradual relocation of periodontal tissue fluids. Blood flow is reduced in areas of 
compression, but maintained or increased in areas of tension.  Changes in blood flow 
may be in the order of 50 percent, with vascular endothelial junctions being important 
pathways for fluid transport (Tang et al., 1993).  Reduction in blood flow lowers 
oxygen tension and a mild inflammatory reaction develops (Tuncay et al., 1994). 
Recruitment of different cell types produces a local environment rich in biologically 
active substances, further modulated by systemic factors; parathyroid hormone, 
calcitonin and vitamin D, that can also influence the production of cytokines and 
prostaglandins (Dewhurst et al., 1987).  
 
Fibroblasts within the periodontal ligament are involved in collagen turnover and 
mediate biochemical transfer of the mechanical force applied orthodontically to the 
teeth and to the surrounding tissues, including the alveolus.  Biochemical signals 
involved in this process include prostaglandins, neurotransmitters, cytokines and 
interleukins (Ten Cate et al., 1976).  Intracellular events including the elevation of 
intracellular calcium follow the direct stimulation of isolated fibroblasts by hydraulic 
pressure (Nakago-Matsuo et al., 1996).  Raised levels of intracellular calcium cause 
cellular responses, including proliferation, differentiation and the secretion of 
additional biological signals (Berridge, 1993). 
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1.2.5.3  Piezo-electric theory 
Piezoelectric theory relates the generation of electrical charge following the distortion 
of bone matrix.  Applied stress results in a reorientation of matrix proteoglycans 
which induce changes in cell membrane polarity and activation of membrane enzymes 
(Grimm, 1972). This leads to cell-membrane interactions and the opening or closing 
of stress-related ion channels (Davidovich, 1991).  McDonald and Yettram (1995) 
examined the effects of mechanically loading bone on the ionic distribution in 
osteocytes.  They found that when an external force was applied to osteocytes there 
was a change in the sodium ion and a great change in potassium ion distribution 
within the cells , but no change in chloride ions.  A similarity between the pattern of 
distribution of strain energy density and the ions within the osteocytes was also seen.  
 
Areas of compression become electronegatively charged whilst areas of tension 
become electropositively charged.   The end result is that bone is resorbed and 
deposited simultaneously, the turnover equilibrium being shifted to favour one or the 
other at different times. For remodelling to occur the strain level should exceed a 
value of 0.02N (Frost, 1983).  Finite element analysis has shown that this level can be 
exceeded in the periodontal ligament (Middleton et al., 1996).  The periodontal 
ligament appears to experience higher strains than adjacent bone and dentine.  
Middleton et al. (1996) suggested that bone may not experience sufficient strain to 
begin remodelling during normal orthodontic loading. 
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1.2.6 Effect of orthodontic forces on the periodontum 
1.2.6.1 The gingival tissues 
The perceived benefits resulting from orthodontic treatment must be weighed against 
the potential harm, including the development of plaque-induced gingivitis and 
gingival hyperplasia.  These conditions may be reversible alter appliance removal and 
appropriate oral hygiene measures (Zachrisson and Zachrisson, 1972) or they may 
require surgical intervention. 
 
Pseudopocketing of the periodontium may arise because of an increase in gingival 
margin height relative to the cemento-enamel junction (CEJ). It is therefore 
reversible, maximum reduction in pocket depth occurring within one month following 
appliance removal and institution of oral hygiene methods.  Further reductions 
continue for up to four months post treatment.  There is no significant difference in 
pocket depth between test and control teeth after two years in healthy adolescent 
patients (Zachrison and Alnaes, 1973).  Therefore, orthodontic treatment does not 
seem to have any permanently damaging effects upon the gingival tissues in healthy 
adolescent patients. 
 
1.2.6.2  Connective tissue attachments 
There is individual variation in the attachment losses experienced by different 
subjects. Boyd et al. (1989) found no clinically significant attachment losses in 
adolescents and adults following orthodontic treatment, if normal periodontal tissues 
were present before and throughout treatment (Boyd et al., 1989). However, 
Zachrisson and Alnaes (1973) found a statistically significant difference in mean 
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attachment loss between an orthodontically treated group (0.41mm) and an untreated 
control group (0.11mm) with certain individuals losing 2mm of attachment at some 
sites (Zachrisson and Alnaes 1973).  Similarly Hamp et al. (1982) found a 0.28mm 
bone loss around bonded teeth during treatment compared to 0.22mm in the control 
group over the same period.  Several explanations may account for the 
control/treatment group variation in these studies.  It is difficult to evaluate 
attachment loss with accuracy as a result of differing methodologies, oral hygiene 
levels, tissue inflammation, probing force, probing angle, probe design, appliance 
types, differing gingival-bracket distances, position of the probe around the gingival 
margin, and visibility of the probe’s scale to the operator. 
 
The amount of force used during tooth movement is thought to influence loss of 
alveolar bone during orthodontic treatment (Reitan 1974).  In the absence of plaque 
and with orthodontic forces at physiological levels, bone loss should not occur as a 
result of orthodontic movement (Eliasson et al., 1982).  
 
It is incorrect to assume that “physiological” force levels are those that would not 
produce a pathological reaction in all cases, since the threshold values for bone 
remodelling vary between individuals.  As the pathological reaction of greatest 
concern is root resorption one does not know if this sequel is present unless 
radiographs are taken and it may be that the incidence of root resorption is higher than 
that reported.  Other influences on crestal bone include closure of extraction sites and 
the effects of calculus and plaque when they are moved from a supragingival 
environment following tooth up righting (Zachrisson and Zachrisson, 1972). 
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Patient age during orthodontic treatment also influences the potential risk of alveolar 
bone loss.  Adults may experience greater amounts of bone loss than adolescents, 
since the experience of periodontal disease is higher in this group (Reitan, 1954; Van 
Der Velden, 1984).  Also, it is rare to find significant alveolar bone loss in the early 
teenage years.  Zacharrisson and Alnaes (1974) looked at 51 adolescents with a Class 
II division I malocclusion treated following extraction of upper first premolars and 
compared them to an untreated group.  Standardised radiographs demonstrated a CEJ 
to alveolar crest distance of 1.1mm in the treatment group compared with 0.88mm in 
the control, so that orthodontic treatment was associated with 0.22mm additional bone 
loss (Zachrisson and Alnaes, 1974). 
 
Orthodontic treatment at that time (1970s) involved the use of bands cemented to the 
teeth to carry the bracket into which the orthodontic wires were fitted.  Often such 
bands could only be placed subgingivally in order to obtain a correct position of the 
bracket on the tooth and this may have produced bone loss.  Modern appliances use 
the acid etch technique to attach brackets to the tooth, brackets are much smaller than 
bands and subgingival positioning is thus far less common.  Also brackets are usually 
placed only on the buccal surfaces of the teeth.  
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1.2.6.3 Periodontal health monitoring in the orthodontic patient 
Gingival and periodontal diseases are largely diagnosed by visual criteria and physical 
examination of the periodontal tissues using probes of various designs. During a 
periodontal examination the clinician looks for several specific indicative factors, 
including; 
o Tissue colour and contour 
o Presence of bleeding on probing 
o Extent of gingival recession 
o Probing pocket depth and attachment levels 
o Presence of suppuration 
o Degree of tooth mobility 
o Presence, position, number and size of tooth furcations 
o Radiographic evidence of bone loss  
 
These methods are largely qualitative and are dependent on the preferences and 
estimations of the individual clinician, leading to possible variation in results, unless 
the clinician is calibrated.  Also, the assessments are subjective measures of historical 
disease and are therefore difficult to use as a means of predicting the course and 
severity of progressive periodontal disease. Variables involved include probe 
dimensions, construction, placement and reference point, probing force, gingival 
tissue condition, tooth alignment and shape, and the presence of subgingival deposits.   
 
In order to evaluate progressive inflammatory disease a series of clinical indices were 
developed during the 1960s and 1970s based upon evidence of tissue damage.  
Despite short comings, these indices remain in widespread use and provide a simple 
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means for determining and recording the progression of periodontal diseases over a 
period. 
 
1.2.6.3.1 BPE - Basic Periodontal Examination 
The Basic Periodontal Examination is a screening assessment to identify the presence 
or absence of periodontitis, it requires that the periodontal tissue should be examined 
with a standardised periodontal probe using light pressure to test for bleeding, plaque 
retention and pocket depth. The dental arches are divided into sextants and the worst 
score per sextant is recorded using a hierarchical index. 
 
1.2.6.3.2 Plaque levels 
The plaque index is a clinical measure of the quantity of plaque at a specific tooth 
site.  Variations include the Plaque index (Loe, 1967) and the Turesky modification of 
the Quigley Hein index (Turesky et al., 1970). The latter is one of the most commonly 
used.   Orthodontic tooth movement requires appliances which are bulky and plaque 
retentive and so Ciancio et al. (1985) developed a bonded bracket plaque index to take 
account of this.   
 
 
1.2.6.3.3 Severity of gingivitis 
The gingival index is a qualitative clinical measure of inflammatory changes within 
the gingival tissues (Loe, 1967).  
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1.2.6.4 Force delivery systems to generate orthodontic tooth movements 
Three variables affect the biological response to orthodontic force: force magnitude; 
duration; and means of application.  
 
1.2.6.4.1 Force magnitude 
Light forces have been recommended for efficient and less painful tooth movement 
(Hixon et al., 1969).  However the rate of tooth movement bears little relation to force 
magnitude (Andreason and Zwanziger, 1980). It can therefore be suggested that the 
importance of light forces lies not in the production of an optimal rate of tooth 
movement, but in limiting the undesirable side effects of heavy forces which increase 
the risk of radicular damage, however the forces that produce these side effects vary 
amongst individuals making it difficult to discern what a heavy force is (Owan-Moll 
et al., 1996).  Optimal forces for given tooth movements are listed in Table 1.1. The 
surface area within the periodontium changes along the length of the tooth as teeth 
taper apically, therefore the forces required for intrusive movements are very low.  
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Table 1. 1 Ideal force levels to achieve different types of tooth movement (taken 
from Laura Mitchell. An Introduction to Orthodontics. 2nd Edition. Oxford. 2001) 
 
Type of movement Force required (g) 
Tipping 30-60g 
Bodily movement 100-150g 
Rotation 50-75g 
Extrusion 50-75g 
Intrusion 15-25g 
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1.2.6.4.2 Force duration 
A light, continuous force is the most efficient for producing tooth movement and 
heavy, continuous forces should be avoided.  Interaction between force magnitude 
and the duration is complex since the applied force components can be subject to 
rapid force decay with time, especially those made from elastic polymers.  Nickel-
Titanium (NiTi) wires used in the initial phases of treatment do not obey Hooks Law 
i.e. the loading/unloading curve is not a straight line. 
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1.2.6.5 Mechanisms of force application 
Nickel-Titanium alloys have two properties; super-elasticity and shape memory.  
These properties offer advantages during orthodontic tooth movements.  Super-
elasticity is the ability to demonstrate a non-linear loading curve such that the wire 
will exert the same force whether it is deflected a short or long distance.  Constant 
force delivery over a range of activation during use is thought to be an efficient 
method of force delivery (Miura et al., 1988). 
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1.2.7 Force application measurement 
The simplest method for measuring force is with the use of an intraoral Corex tension 
gauge. Several studies have compared different means of force application to find the 
most efficient means of space closure (Dixon et al., 2002; Nightingale and Jones, 
2003).  All of these studies have concluded that the NiTi coil springs produce the 
most constant and effective force and this is the method of force application to be 
used in the present study.   
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1.2.8 Tooth movement measurement 
Assessment of the rate of orthodontic tooth movement involves measurement of 
distance and time.  It is difficult to determine the distance over which each tooth 
moves during treatment because all teeth involved in the appliance move by varying 
degrees in varying directions.  Anatomical structures have been used as reference 
points, for example palatal rugae, although the identification of suitable fixed 
structures during appliance therapy can be problematic (Almeida et al., 1995). 
Baldwin et al., (1999) used a reflex metrograph at six weekly intervals to calculate the 
three dimensional tooth movements produced by NiTi archwires.  
 
Another method of assessing tooth movement is to measure the linear displacement of 
anatomical contact points using a dial calliper.  During orthodontic alignment the 
teeth line up so that contact point displacement reduces with time.  This can be used 
to indicate the rate of achievement of alignment and hence act as an indicator for rate 
of tooth movement. Such a method was first developed by Little, (1975) and used as 
an indicator of stability in lower incisor position following orthodontic treatment over 
time. 
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1.2.9 Gingival crevicular fluid 
1.2.9.1 The gingival crevice 
The gingival crevice is a relatively fragile tissue barrier, which separates the internal 
tissues of the body from a hostile external environment, the mouth. In health this 
barrier is known as the junctional epithelium.  It is non-keratinised and permeable and 
so allows materials from the mouth to pass into the periodontium and vice versa.  
1.2.9.2 The formation of gingival crevicular fluid (GCF) 
The gingival crevice contains fluid that is derived from beneath the gingival margin.  
In health this gingival crevicular fluid (GCF) is a serum transudate and therefore 
contains all of the components of serum and some cellular elements, in particular 
polymorphonuclear leucocytes (PMNL). 
 
A local osmotic gradient is responsible for the movement of fluid from intravascular 
to perivascular sites.  During the process various substances may be incorporated into 
the fluid, reflecting the biology and physiology of the surrounding tissues.  In health 
GCF composition reflects the physiological processes underlying normal tissue 
turnover, in gingivitis and periodontitis it becomes an inflammatory exudate 
developed in response to inflammatory and immunological reactions.  Similarly, 
during orthodontic tooth movement the composition of the fluid may alter to reflect 
periodontal connective tissue turnover. 
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1.2.9.3 The composition of gingival crevicular fluid 
As a result of the permeability of the junctional epithelium, even in clinical health 
there exists a degree of infiltration of inflammatory cells in the periodontium.  Once 
disease is established the gingival connective tissue becomes a site of acute 
inflammation.  The cardinal signs of acute inflammation are seen clinically within the 
gingival tissue, which becomes red, swollen and oedematous, a cellular PMNL 
infiltration becomes evident.  With time the normally thin junctional epithelium 
becomes punctuated with microulcerations and may bleed easily with applied 
pressure.  Therefore, in gingivitis and other inflammatory diseases of the 
periodontium the serum transudate becomes an inflammatory exudate.  As previously 
mentioned, during orthodontic treatment inflammatory reactions are also generated, 
one initiated by pressure gradients within the periodontal membrane, the second 
resulting from the microbial plaque challenge.   
 
Substances that may be involved in connective tissue remodelling have been studied 
by measuring their concentrations in GCF.  Last et al., (1988) found an increase in 
chondroitin sulphate (a type of glycosaminoglycan) on the side to which teeth were 
moved orthodontically.  Grieve et al., (1994) found that levels of prostaglandin E and 
interleukin 1 " increased over a period of 24-48 hrs following the initiation of tooth 
movement.  Lactic and citric acid levels also increase during tooth movement 
(Miyajima et al., 1991).  Plasminogen activator and plasminogen activator inhibitor 
have been studied in health, gingivitis and periodontal disease (Xiao et al., 2000).  
These and other studies may enable measurements of the constituents of GCF to be 
used to monitor biological events in particular during orthodontic tooth movement.  
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1.2.9.4 Collection of gingival crevicular fluid 
The most commonly used sampling method uses a paper strip inserted into the 
gingival crevice until mild tissue resistance is felt.  It is left in position for a known 
period of time whilst GCF is absorbed into it (Brill and Krass, 1958).  A sampling 
period of 30s has been adopted by most investigators with the use of a methyl 
cellulose collecting strip.  The composition of GCF varies with the amount of gingival 
inflammation (Curtis et al., 1988).  In order to illustrate the levels and change in 
levels of collected GCF compounds the sample may be assessed using the total 
amount collected over a pre-determined period. (Chapple et al., 1999)   
 
1.2.9.5 Previous orthodontic studies using GCF 
The presence/expression of regulatory proteins within GCF has been recognised as a 
measure for monitoring orthodontic treatment outcome.  Reports have focused on the 
presence of new mediators and on regulation of the levels of these proteins.  
 
Some studies have investigated one or two proteins only due to the limitations of the 
available assays.  Different time points have been selected for sampling and different 
sampling methods used.  Orthodontic appliances and movements vary between 
studies and different test teeth have been used.  This makes it difficult if not 
impossible to compare studies many of which are under powered. 
 
A meta-analysis on the role of GCF cytokines in orthodontic tooth movement has 
been attempted with a view to generating a time-related pattern for the production of 
GCF cytokines that may provide evidence at the cellular level.  The meta-analysis 
was not justified due to the heterogeneity of the reports Many studies did not 
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discriminate between sites of tension and compression or only took samples from 
compression sites. (Ren and Vissink, 2008) 
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1.2.10 Inflammatory cytokines  
Orthodontic tooth movement is a type of tissue injury leading to an inflammatory 
response (Davidovitch, 1991). Endothelial cells are activated and cytokines and 
chemoattractants that result in leukocyte activation are produced (Cooper and Sims, 
1989).  This interaction between endothelial cells and leukocytes is important in the 
inflammatory process, as it produces pro-inflammatory cytokines (PIC) and anti-
inflammatory cytokines (AIC) (Maroszynska and Fiedor, 2000).  PICs and AICs are 
bioactive molecules which maintain and regulate the inflammatory process by 
paracrine and autocrine signalling (Callard et al 1999).  Cytokines that affect bone 
metabolism, and thereby orthodontic tooth movement, include interleukin1(IL-1), 
interleukin2(IL-2), interleukin 3 (IL-3), interleukin 6 (IL-6), interleukin 8 (IL-8), 
tumor necrosis factor alpha (TNF!), interferon-# (IFN#), and osteoclast differentiation 
factor (ODF) (Krishnan and Davidovitch, 2006). Studies in bone remodeling have 
indicated that certain PICs, such as interleukins (IL-1b, -6, and -8) and tumor necrosis 
factor-alpha (TNF-a), are important regulators in the bone remodeling process upon 
mechanical stimulation (Ren et al., 2007). The most potent among these is IL-1, 
which directly stimulates osteoclast function through the IL-1 type 1 receptor, 
expressed by osteoclasts. IL-1 secretion is triggered by various stimuli, including 
neurotransmitters, bacterial products, other cytokines, and mechanical forces 
(Davidovitch, 1995). IL-1 has two forms coding different genes.   IL-1 attracts 
leukocytes and stimulates fibroblasts, endothelial cells, osteoclasts, and osteoblasts to 
promote bone resorption and inhibit bone formation (Sabatini et al., 1988).  
Osteoblasts are target cells for IL-1, which in turn activate osteoclasts to resorb bone 
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(Davidovitch, 1995). IL-1! is a key mediator in a variety of activities in immune and 
acute-phase inflammatory responses (Dinarello, 1989).  
 
IL-6 regulates the immune response at inflammation sites and stimulates osteoclast 
formation and the bone-bioabsorbing activity of preformed osteoclasts. (Okada and 
Murakami 1998; Dinarello, 1989).  IL-8 regulates the influx of leukocytes at a site of 
inflammation. It also is a potent neutrophil chemoattractant and activator that is 
secreted by monocytes, macrophages, epithelial cells, and fibroblasts, all of which are 
abundant in the periodontal environment. (Ren et al., 2007).   Tuncer et al., 2005 
reported increased levels of IL-8 at PDL tension sites and proposed it to be a 
triggering factor for bone remodeling. TNF!, another pro-inflammatory cytokine, was 
shown to elicit inflammation and stimulate bone resorption. TNF! is  synthesised and 
released by monocytes and macrophages by activation of leukocytes in vitro and is a 
potent inducer of bone resorption (Bertolini et al., 1986).  Davidovitch et al., 1988; 
Satio et al., 1990; Alhashimi, 2000 and Alhashimi, 2001 have shown that TNF! 
directly stimulates the differentiation of osteoclast progenitors to osteoclasts in the 
presence of macrophage colony-stimulating factor (M-CSF). Davidovitch et al., 
(1988) and Saito et al., (1990) demonstrated marked increases in the staining intensity 
for IL-1 and TNF! in cells of the PDL and alveolar bone during orthodontic tooth 
movement.  
 
In contrast to interferon-! and interferon-", which can be expressed by all cells, 
interferon-" (IFN#) is secreted by T lymphocytes and natural killer cells only and is 
the only Type II interferon. It is serologically distinct from Type I interferons and it is 
acid-labile, while the Type I variants are acid-stable. IFN# has antiviral, 
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immunoregulatory, and anti-tumour properties (Schroder et al., 2004). It alters 
transcription of  at least 30 genes, producing a variety of physiological and cellular 
responses. Activation by IFN# is achieved by its interaction with heterodimeric 
interferon # receptors. IFN# suppresses osteoclast formation by rapidly degrading the 
RANK adaptor protein TRAF6 in the RANK-RANKL signalling pathway, which 
otherwise stimulates the activation of the transcription factor NF$B.  
 
Chapter 1  Introduction and Background 
 35 
1.2.11 Tissue metabolites 
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases of the matrixin 
family (Nagase,
 
 1999).  Most are secreted as inactive enzymes (pro-enzymes) which 
are activated in the extracellular compartment or in the vicinity of other MMPs or 
serine proteases (Nagase, 1997).  The proteolytic activity of MMPs is under the 
control of circulating and endogenous tissue specific inhibitors which control extent 
of extracellular matrix remodelling (Starkey and Barrett, 1973). 
The main substrates of the gelatinases are Type IV collagen and gelatin, The 
gelatinases are MMP-2 and MMP-9. MMP-2, MMP-9 and TIMPs-1 and 2 are thought 
to be important in bone metabolism (Birkedal-Hansen et al., 1993).  
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1.2.12 Bone metabolites 
RANKL (Receptor Activator for Nuclear Factor $ B Ligand) and OPG 
(osteoprotegenrin) are members of the TNF super family and regulate bone resorption 
(Lerner 2004).  RANKL  is membrane bound and can be found on osteoblasts, 
fibroblasts and activated T and B cells.  Its osteoclastogenic action is blocked by the 
soluble decoy receptor OPG, whose expression is tightly regulated by systemic and 
local stimuli. RANKL is a principle osteoclast activator, produced by osteoblasts.  
Nulizygous mutant mice with deletion of the RANKL gene have been found to be 
osteopetrotic as there is no osteoclast activity due to the absence of an osteoblast 
signal.  When RANKL protein was injected into these mice the ostopetrosis reversed.  
RANKL has also been shown to be important for the differentiation of osteoclasts 
from their monocytic precursors.  RANKL increases and OPG levels decrease in GCF 
samples during orthodontic tooth movement (Mogi et al., 2004).  
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Figure 1.1 The bone remodelling cycle and metabolite interactions (adapted from a diagram at www.endotext.org) 
!
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1.3 Aims of the study 
The aim of the present study is to investigate the effects of orthodontic tooth 
movement on the periodontium by analysing cytokine, protease and protease-inhibitor 
protein levels within GCF.  Arrays will be employed to profile several biomarkers 
simultaneously within GCF and to correlate changes in protein profiles with differing 
applied forces and also between zones of tension and compression. 
 
The objective of the proposed study is to improve our understanding of tissue changes 
induced by orthodontic forces, with view to a better understanding of differing rates 
of tooth movement and adverse events. 
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1.4 Hypotheses 
The null hypotheses were that when an orthodontic force was applied to a tooth; 
 
1) There is no change in the biomarker profile in GCF.  
 
2) There is no difference in the GCF biomarker profiles at the compression and 
tension sites. 
 
3) There are no correlations between the various cytokines tested and the rate of tooth 
movement. 
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2.1 Materials 
Orthodontic materials: 
MBT prescription brackets (3M Unitek)  
0.014 Nikel Titanium Archwires 
0.018 Nikel Titanium Archwires 
0.018 Stainless Steel Archwires 
9mm NiTi closing coil springs  
Intra oral tension guage ( Correx) 
Long ligatures 
Elastomeric modules (TP orthodontics) 
 
Alginate impression material 
Impression trays 
 
Periodontal materials: 
WHO probe 
Periopaper Strips
 TM
 
Periotron 8000
 TM
 
 
Chapter 2  Materials and Methods 
 42 
Laboratory materials: 
MMP-9 and TIMPs (1, 2, 3 & 4) were measured using Fluorokine MAP kits from 
R&D systems (Abingdon, UK).   
RANKL and OPG were measured using LINCOplex kits from Millipore (Watford, 
UK).  
Cytokines (GM-CSF, IFN!, IL-1", IL-2, IL-4, IL-5, IL-6, IL-8, IL-10 and TNF#) 
were measured using the Cytokine 10-plex kit from Invitrogen (Paisley, UK). 
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2.2 Methods 
2.2.1. Ethical approval 
Prior to the commencement of the study ethical approval was obtained from the 
Coventry Research Ethics Committee (Reference number 08/H1210/72). Potential 
subjects and parents were given all the relevant information both verbally and in 
writing at their first attendance to the orthodontic clinic.  They were then given at 
least a week to review and digest the information before being consented to join the 
study.  Information and consent forms are shown in Appendix A1. 
 
2.2.2 Patient recruitment 
This is a pilot study.  Due to the size and nature of this study and lack of previous data 
we could not calculate a sample size. However, studies of individual biomarkers 
demonstrate significant changes detected with time during periodontal disease activity 
on 10-20 volunteers, where change is measured longitudinally within the same 
subjects at a power of >0.08 (P<0.05) (Brock et al., 2004, Wright et al.,2003).  Thus 
we aimed to recruit a minimum of 20 subjects and planned to do a post hoc sample 
size calculation to aid future research.  
 
21 consecutive subjects were invited to take part in the study as they attended the 
Birmingham Dental Hospital to begin a course of orthodontic treatment.  Inclusion 
and exclusion criteria are shown in Table 2.1.  
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Table 2.1 Inclusion and exclusion criteria 
Inclusion Criteria Exclusion Criteria 
Aged 12-20 years Smokers 
Good systemic health Have a full mouth plaque and bleeding 
score of >20% 
 
Competent Probing depth values >4mm 
 
About to undergo a course of orthodontic 
therapy with fixed appliances 
Radiographic evidence of periodontal 
bone loss 
 
Requires removal of both upper first 
premolar teeth 
Courses of anti-inflammatory or 
antimicrobial treatments taken within 1 
month prior to study 
 
Has upper canine teeth fully erupted 
within the oral cavity 
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2.2.3 Treatment 
  
A detailed periodontal examination was carried out, to record plaque index, bleeding 
on probing and bleeding  index. Gingival crevicular fluid (GCF) samples were taken 
from the test teeth (the maxillary canine teeth) and upper arch impressions were 
taken.  During the next few weeks the maxillary first premolar teeth were extracted 
and one week was allowed for gingival healing before attachment of the straightwire 
appliance.  All subjects had the same bracket system (MBT prescription), elastomeric 
modules (TP orthodontics) and archwire sequence. After three months into appliance 
treatment and after tooth extraction, having followed a normal archwire progression 
(0.014 Nikel Titanium!0.018 Nikel Titanium !0.018 Stainless Steel). Archwire 
changes were made at 6 weeks and 10 weeks, the 0.018 Stainless Steel archwire being 
placed at 10 weeks.  4 weeks later the distalising force was applied to the test tooth. 
This delay was to ensure that the teeth had aligned onto the archwire before the 
distalising force was applied to move the canine tooth so that the biomarker changes 
detected were due to mesiodistal and not buccopalatal tooth movement.  4 weeks after 
the stainless steel archwire was placed, another detailed periodontal examination, 
upper arch impression and GCF collection was undertaken, (Test point T1). After  
samples were taken at T1 a 9mm NiTi closing coil spring was placed between hooks 
on the brackets of the upper canine and the first molar with the aid of a ligature.  The 
ligature was tightened to produce a force of 100g according to the intra-oral tension 
guage.  At T2, T3 and T4 detailed periodontal examinations, upper arch impressions, 
GCF collections and force adjustments were carried out (Figure 2.2).   
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Figure 2.1 A  straightwire appliance with upper and lower Stainless Steel 
archwires. 
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Figure 2.2 Summary of periodontal assessement and sample collection along the 
course of the study.  
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2.2.4 Gingival Crevicular fluid 
 
2.2.4.1 Calibration of Periotron 8000
TM
 . 
The Periotron 8000  was calibrated by adding 35 known fluid volumes to periopaper 
strips, using Hamilton positive pressure syringes.  The numerical readings given by 
the Periotron  per volume were recorded.  Each volume was tested thrice to minimise 
error and the Periotron was cleaned and dried between samples (Appendix B.1). 
 
The mean value per volume was calculated and a calibration curve plotted.  A fourth 
polynomial regression equation was formulated, from the mean values, and this 
formula was used to create a reference table that related volumes to the numerical 
readings shown on the Periotron 8000 (Chapple et al., 1999a) (Appendix B.2). 
 
2.2.4.2 Collection of GCF 
Prior to sample collection the test area was isolated with cotton-wool rolls and the 
teeth were air dried using a triple air syringe to remove saliva.  The air was blown in a 
downwards direction to avoid drying the gingival crevice.   GCF samples were 
collected using Periopaper strips
 TM
 placed into the gingival crevice for 30 seconds 
until mild tissue resistance was felt (Brock et al., 2004).  A Periopaper strip  was then 
placed into the jaws of  the calibrated Periotron 8000
 
to be read.   Figure 2.3 shows 
the insertion of a Periostrip  into a distobuccal position.  In each subject and at each 
study time point individual Periopaper strips were placed into the gingival crevice at 
the mesiobucal and distopalatal aspects of both maxillary canine teeth. Samples were 
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then combined separately for compression and tension sites.  Each pair of strips were 
eluted into sterile PBS (200 µl) and stored under liquid nitrogen until assay. 
 
Mesiobuccal and distopalatal sampling sites were chosen to represent tension and 
compression.  Because these are diametrically opposite, the risk of drawing GCF 
round the crevice from one site to the next is minimised. 
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Figure 2.3 Periostrip in a distobuccal position relative to the upper left central 
incisor. 
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2.2.5 Measurement of periodontal indicies 
2.2.5.1 BPE (Basic Periodontal Examination) 
Probing depth was measured as part of the BPE screen using a WHO ( World Health 
Organisation) E-type probe. The gingival crevice surrounding each tooth was probed 
for bleeding, plaque retention and pocket depth.  The following scores were applied: 
 
0 No bleeding or pocketing or plaque retention detected 
1 Bleeding on probing - no pocketing > 3.5mm and no plaque retention 
2 Plaque retention present - no pocketing > 3.5mm 
3 Pockets > 3.5mm but <5.5mm in depth 
4 Pockets > 5.5 mm in depth 
 
The dental arches were then split into sextants and the worse score per sextant was 
recorded as a general measure of periodontal health. 
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2.2.5.2 Bleeding index 
Full mouth bleeding indices were performed at each visit as a measure of 
inflammation.  The WHO E type probe was placed into the gingival margin of each 
tooth in turn and run around its circumference.  Each tooth was then split into mesial, 
distal, buccal and palatal sites for recording purposes. 
 
A score of 1 was given per site if bleeding was present and a score of 0 if it was 
absent.   All scores were added to give the total number of sites expressed as a 
percentage. 
 
Number of sites scoring 1   x  100 = Percentage of the mouth with bleeding sites. 
Total number of Sites 
 
2.2.5.3 Plaque levels 
Full mouth plaque indices were obtained at each visit.  A disclosing dye was applied 
to the teeth, the subject was then asked to rinse the mouth to remove excess dye.  
 
A score of 1 was given per site if plaque was evident and 0 if it was not.   Scores were 
added and the total number of sites calculated as a percentage. 
 
Number of sites scoring 1     X  100 = Percentage of sites with plaque 
Total number of sites                                                 
 
 
A separate more detailed plaque score was then calculated for each of the upper 
canines using the Tureskey modification of the Quigley Hein index: 
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Code 0= No plaque at the site examined following disclosure. 
Code 1= A fine broken line of plaque present at the gingival margin of the 
examination site. 
Code 2= A fine unbroken line of plaque present at the gingival margin of the 
examination site. 
Code 3= Plaque covering up to a third of the crown from the gingival margin. 
Code 4= Plaque covering up to two thirds of the crown from the gingival margin. 
Code 5= Total tooth coverage. 
 
This was recorded for the same four sites on these teeth (mesial, distal, buccal, 
palatal). 
 
 
2.2.6 Impression taking 
Alginate impressions of the upper arch were taken at all sampling stages in order to 
monitor tooth movement.  The impression was then disinfected and moved into the 
laboratory for model casting.  
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2.2.7 Force application 
Three months into the fixed orthodontic treatment, at T1, the 9mm NiTi coil springs 
were placed with the aid of a ligature, between the hook on the canine bracket and the 
hook on the first permanent molar attachment.  The 9mm NiTi closing coils were then 
stretched, with the aid of the ligature and an intra oral tension guage (Correx) was 
used to ensure that 100g of force was being applied.   At the following appointment 
the force was checked if necessary the ligature was tightened until the force returned 
to 100g. 
 
 
 
Figure 2.4 A 9mm NiTi closing coil spring stretched on a ligature between the 
upper canine and upper first molar ( taken from http://www.orthocare.co.uk) 
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 Figure 2.5 An intra oral tension guage (Correx) (taken from 
http://www.orthocare.co.uk) 
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2.2.8 Multiplex assay 
After collection, the GCF samples, were thawed on ice and aliquoted (50ul), so that 
repeated freeze-thaw cycles could be minimised.  Biomarkers were detected using 
Luminex multi-analyte technology.  Samples were defrosted and volumes of fluid 
extract were used for each assay (Table 2.2).  Samples were incubated with antibodies 
immobilized on colour-coded microparticles, to detect molecules of interest, washed 
to remove unbound material and then incubated with biotinylated antibodies also to 
the molecules of interest. After further washing a streptavidin-phycoerythrin 
conjugate was added before a final washing to bind to the biotinylated antibodies. 
Figure 2.6 shows the capture of an analyte and the detection of that analyte by the 
recognition of the bead and the quantitation of the fluorescent phycoerythrin signal by 
two lasers.  The Luminex analyzer determines the magnitude of phycoerythrin 
derived signal in a microparticle-specific manner.  
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Table 2.2 Volumes of GCF used in multiplex assays 
Analytes Volume of 
extract 
Kit Manufacturer  
TIMPs (1, 2, 3 & 4) 1"l R&D  
MMP-9 1"l R&D 
OPG 25"l Millipore 
RANKL 25"l Millipore 
Cytokines (GM-CSF, IL-1", IL-2, IL-4, IL-5, 
IL-6, IL-8, IL-10, IFN !, TNF#) 
50"l Invitrogen 
 
 
Figure 2.6 Principle of Luminex assay (taken from University of Pittsburg 
Cancer Institute website http://www.upci.upmc.edu/luminex/sources.cfm)  
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2.2.9 Statistics 
Differences in individual GCF analytes across the course of the study were analyzed 
by non-parametric statistics (Kruskal-Wallis with Dunn’s post test).  
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3.1 Introduction  
When looking for changes in GCF it is important to record bleeding and plaque 
indices at all time points to know if the changes were due to alterations in GCF 
constituents following tooth movement and not due to confounding factors such as 
poor oral hygiene (indicated by high plaque and bleeding scores).   Changes in GCF 
volumes were recorded in order to calculate biomarker levels as “total amount” per 30 
second sample time as well as concentration.  
 
This chapter presents clinical measurements taken at each time point to establish the 
status of the periodontal tissues during orthodontic treatment. Values include GCF 
volume, plaque index, gingival index and tooth movement.  
 
3.2  Tooth movement 
 
The distance between contact points on the upper canines and the second premolars 
was measured from study models.  Measurements were repeated three months after 
the start.  The percentage coefficient of variation for these measurements was low, 
showing high levels of intra-examiner agreement (CV % mean 0.17 range -6.45 to 
8.54). 
 
Averages of the two measurements were used for data analysis.  The averages for left 
and right at each time point were combined and divided to give an average value of 
tooth movement of the upper canines (Figure 3.1A). There were significant changes 
(p<0.001) in tooth movement between T1 (before distalising force was applied) and 
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T4 (distalising force active for six weeks), and between time points T2 (distalising 
force active for four hours) and T4 (Figure 3.1A).  A general trend can also be seen 
for space decreasing steadily from T2 to T3 to T4.  
 
The speed of tooth movement was calculated by dividing the distance moved by the 
time taken (Figure 3.1B). 
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Figure 3.1A&B – Clinical measurements of tooth movement, from maxillary 
canines and the speed of tooth movement between the different time points(mean 
+/- sem). Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; ***p<0.001. 
 
A 
B 
1B 
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On the basis of the tooth movement results the subjects were divided into three even 
groups; those whose teeth moved fastest, those with medium movement and those 
with slow movement, so that other measurements might be stratified for speed of 
movement (Figure 3.2). 
 
 
 
Figure 3.2 – Overall tooth movement, of maxillary canines (T4-T1) Dotted lines 
represent tertile divisions into the three tooth movement speed groups (slow, 
medium and fast movers) and parallel solid line represents the median. 
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3.3  Plaque index 
There were no significant differences in full mouth plaque scores between any of the 
time points (Figure 3.3), demonstrating that appliance wear did not compromise 
plaque removal.  Plaque levels around the upper canines and second molars did not 
alter with appliance placement or when a spring and distalising force was applied 
(Figure 3.4A). However, there was a trend indicating that the mesiobuccal aspect of 
the upper canines (tension site) harboured more plaque than the distopalatal aspect 
(compression site) (Figure 4A).  The reverse can be said of the second molars with the 
mesiobuccal (tension site) harbouring more plaque (figure 3.4B). 
 
Plaque scores at tension sites were found to be significantly greater at canines when 
compared to second molars at T1 (P<0.001) , T2 (P<0.05), T3 (P<0.001) and T4 
(P<0.01).  At the compression sites there was significantly more plaque on the second 
molars than the canines at T1(P<0.05). 
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Figure 3.3 Full mouth plaque scores at each time point. Box and whisker plots 
represent median, 25% and 75% ranges and highest and lowest values. 
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Figure 3.4A&B – Clinical values and scores for Plaque levels (mean +/- SEM), 
for sites of tension (red) and compression (blue) from maxillary canines and 
second molars. Dotted lines represent mean values at baseline and parallel solid 
lines represent the sem of the baseline values. Statistical analysis by Kruskal-
Wallis: *p<0.05; **p<0.01; ***p<0.001.  
B 
A 
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3.4  Gingival bleeding 
Full mouth bleeding scores increased between baseline and T1, indicating that when 
appliances were placed bleeding scores increased (Figure 3.5).  However, this trend 
was not found to be statistically significant.  There was a significant decrease in 
bleeding between time points T1 and T2, when the distalising spring was placed 
 
There was a significant (p<0.05) rise in bleeding mesiobuccal to canines between 
baseline and T1, when appliances were placed (Figure 3.6A).  However the same 
change was not seen at the distopalatal site (Figure 3.6A).  There were no significant 
changes between any of the other time points. At all time points the mesiobuccal 
aspect of the upper canines had a greater tendency to bleed than the distopalatal 
aspect (Figure 3.6A), perhaps indicating a difference in the tension and compression 
sites. 
 
The second molars showed no significant changes between any of the time points or 
between tension and compression sites (Figure 3.7B). Bleeding scores at the tension 
sites were found to be significantly greater at canines than second molars at T1 
(P<0.001) and T2 (P<0.01). 
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Figure 3.5 – Full mouth bleeding scores at each time point. Box and whisker 
plots represent median, 25% and 75% ranges and highest and lowest values. 
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Figure 3.6A&B – Clinical values and scores for Bleeding levels, (mean +/-SEM) 
for sites of tension (red) and compression (blue) from maxillary canines and 
second molars. Dotted lines represent mean values at baseline and parallel solid 
lines represent the sem of the baseline values. Statistical analysis by Kruskal-
Wallis: *p<0.05; **p<0.01; ***p<0.001.  
B 
A 
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3.5  GCF volume  
GCF volume increased at mesiobuccal canine sites between Baseline and T1 and 
between time points T1 and T2, when the spring was applied, before leveling out 
through time points T3 and T4 (Figure 3.7A). The changes between baseline and T1, 
T2, T3 and T4 were significant (p<0.05). No other volume changes between time 
points were significant.  The GCF volume changes at the distopalatal aspects of the 
upper canines showed similar trends to the mesiobuccal sites, although the changes 
between Baseline and T1 were not significant (Figure 3.7A). However, changes 
between baseline and T2, T3 and T4 were significant (p<0.05). There was no 
statistical difference in GCF volumes between the compression (distopalatal) and 
tension (mesiobuccal) sites at any time (Figure 3.7A). 
 
None of the volume changes at the second molar sites were significantat any of the 
time points.  There was no significant difference between the sites of tension and 
compression around the second molars.  GCF volume was not found to be 
significantly greater or less at canines when compared to second molars.
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Figure 3.7A&B- Clinical values and scores for GCF volume, (mean +/-SEM) at 
sites of tension (red) and compression (blue) from maxillary canines and second 
molars. Dotted lines represent mean values at baseline and parallel solid lines 
represent the sem of the baseline values. Statistical analysis by Kruskal-Wallis: 
*p<0.05; **p<0.01; ***p<0.001.  
B 
A 
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3.6 GCF volume correlations 
3.6.1 GCF correlations to plaque and bleeding scores.  
There was a significant correlation between plaque scores and GCF levels at time 
points T1 for the canine tension site (P<0.01) and T1 for the canine compression site 
(P<0.001).  None of the second molar plaque changes were significantly correlated 
with changes in the GCF volumes around those teeth.  None of the correlation 
between bleeding scores and GCF volumes proved significant at both the canines and 
second molars (Table 3.1). 
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Table 3.1 – Comparisons of GCF volume changes to plaque and bleeding scores 
at tension and compression sites around the maxillary canines and second 
molars.  Statistical analysis using Spearman Rank Correlation. 
!! "#$%$&! !! !! "#$%$&! !! !! '&()$*!+),#-! !! '&()$*!+),#-!
!! .&$'%)$!/%0&! ! ")12-&''%)$!/%0&! ! ")12-&''%)$!/%0&! ! .&$'%)$!/%0&!
!! 3,#45&!! 6,&&*%$7!! ! 3,#45&!! 6,&&*%$7!! ! 3,#45&!! 6,&&*%$7!! ! 3,#45&!! 6,&&*%$7!!
!! 8$*&9! 8$*&9! ! 8$*&9! 8$*&9! ! 8$*&9! 8$*&9! ! 8$*&9! 8$*&9!
6#'&,%$&! !! !! ! :;! :;! ! <:! <:! ! <:! <:!
=51>&-!)?!@A!3#%-'! :;! :;! ! ;BCD! ;B<<! ! ;BCD! ;B<E! ! ;BFD! G;BC<!
/2&#-1#$!-! ;BCC! ;B::! ! ;B<D! ;BHF! ! ;B:E! ;BFI! ! ;B;E! ;BCC!
3!J#,5&!K0L)G0#%,&*M! ;B<F! ;BCH! ! ='! ='! ! $'! ='! ! ='! $'!
!! !! !! ! !! !! ! !! !! ! !! !!
.<! !! !! ! !! !! ! !! !! ! !! !!
=51>&-!)?!@A!3#%-'! :;! :;! ! :;! :;! ! <:! <:! ! <:! <:!
/2&#-1#$!-! !"#$! ;B<F! ! !"%&! ;B:C! ! G;B<D! G;B:F! ! G;B;D! =)!J#,5&!
3!J#,5&!K0L)G0#%,&*M! !"!!%! ;BF:! ! !"!'! ;BCC! ! ;BHI! ;BDC! ! ;BN;! !!
!! !( !! ! !( !! ! !! !! ! !! !!
.:! !( !! ! !( !! ! !! !! ! !! !!
=51>&-!)?!@A!3#%-'! :;( :;! ! :;( :;! ! <:! <:! ! <:! <:!
/2&#-1#$!-! ;B:C( ;B:<! ! ;B<F( ;B;:! ! G;BF<! ;B:F! ! G;B<C! =)!J#,5&!
3!J#,5&!K0L)G0#%,&*M! ;BCC! ;BCE! ! ;BF:! ;BND! ! ;B;N! ;BD:! ! ;BHE! !!
!! !! !! ! !! !! ! !! !! ! !! !!
.C! !! !! ! !! !! ! !! !! ! !! !!
=51>&-!)?!@A!3#%-'! :;! :;! ! :;! :;! ! <:! <:! ! <:! <:!
/2&#-1#$!-! ;BC<! ;B:D! ! ;B;C! ;B:E! ! ;B<D! G;BDH! ! ;BC<! =)!J#,5&!
3!J#,5&!K0L)G0#%,&*M! ;B<N! ;B:N! ! ;BN:! ;B:C! ! ;BHF! ;B<C! ! ;BCC! !!
!! !! !! ! !! !! ! !! !! ! !! !!
.D! !! !! ! !! !! ! !! !! ! !! !!
=51>&-!)?!@A!3#%-'! :;! :;! ! :;! :;! ! <:! <:! ! <:! <:!
/2&#-1#$!-! ;B;;:! ;B<C! ! ;B<D! ;B:D! ! G;BC;! G;B:<! ! ;B;N! G;BCN!
3!J#,5&!K0L)G0#%,&*M! ;BNN! ;BFE! ! ;BFI! ;BC:! ! ;BCD! ;BF<! ! ;BIE! ;B:<!
Chapter 3  Clinical Indices Results 
 74 
3.6.2 GCF correlations to speed of tooth movement.  
No significant correlations were found between GCF volume and speed of tooth 
movement at any time within or between tension and compression sites around both 
canines and second molars. 
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4.1 Introduction  
This chapter presents cytokine levels measured from GCF collected during the 
orthodontic treatment. Ten cytokines were assayed; GM-CSF, INF!, IL-1", IL-2, IL-
4, IL-5, IL-6, IL-8, IL-10, and TNF#.  Four were beneath the detection levels of the 
assays and six will be reported.  Correlations between cytokine levels and clinical 
measures were analysed by Spearman Rank Correlations. 
 
4.2 Interleukin-1! 
There were significant differences between the levels of IL-1" expressed 
mesiobuccally to the upper canine, between Baseline and T2 (p<0.01), Baseline and 
T3 (P<0.05) and Baseline and T4 (P<0.01) (Figure 4.1A).  Significant differences 
between the levels of IL-1" expressed distopalatally to the upper canine were found 
between Baseline and T2 only (p<0.01) (Figure 4.1A).  
 
There were no significant differences between the levels of IL-1! expressed either 
mesiobucally or distopalatally to the upper second molars, between any time points. 
  There were no statistically significant differences in the amount of IL-1! between 
the mesiobuccal and distopalatal aspects of the canines or second molars at any of the 
time points.  Figure 4.1A indicates a trend for lower levels of IL-1! at the distalpalatal 
(compression) sites at all time points except baseline, where they were very similar to 
mesiobuccal (tension) sites. 
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 Figure 4.1A&B – IL-1!  levels (mean +/- SEM), for sites of tension (red) and 
compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
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4.2.1 Associations between clinical indices and IL-1! levels. 
 
Table 4.1 Correlations between IL-1! ,plaque and bleeding indicies and the rate 
of tooth movement.  TS=Tension Sites CS=Compression Sites  *=significant, 
B=borderline significance, ns=no significance. 
 
  Correlations for each time point     
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns ns ns 
Canine CS * * ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns B ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Chapter 4  Cytokine Results 
 79 
 
4.3 Interleukin-6 
There was a significant increase in the level of IL-6 between Baseline and T1 
(P<0.05) and between Baseline and T4 (P<0.05) at the mesiobuccal canine site.  
There was no significant difference in IL-6 levels between any of the time points at 
the distopalatal canine site.(Figureure 4.2A).  There were no significant differences in 
IL-6 levels between any of the time points at the mesiobuccal or distopalatal second 
molar site.(Figureure 4.2B).  There were no statistically significant differences in the 
amounts of IL-6 between the mesiobuccal and distopalatal aspects of the canines or 
second molars at any time  (Figure 4.2A&B). 
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Figure 4.2A&B – IL-6 levels (mean +/- SEM), for sites of tension (red) and 
compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
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4.3.1 Associations of clinical indicies with IL-6 levels. 
  Correlations for each time point      
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
 
Table 4.2 Correlations between IL-6, plaque and bleeding indicies and the rate of 
tooth movement. TS=Tension Sites CS=Compression Sites *=significant, 
B=borderline significance, ns=no significance. 
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4.4 Interleukin-8 
There was a significant increase in IL-8 levels between Baseline and T2 (P<0.001). 
Levels of IL-8 were also significantly higher than at Baseline at T3 (P<0.01) and T4 
(P<0.05) (mesiobuccal tension canine sites).  There was also a significant increase in 
IL-8 levels between Baseline and T1 (P<0.05) at the distopalatal canine site (Figure 
4.3A). 
 
There were however no statistically significant differences in the amount of IL-8 
between the mesiobuccal and distopalatal aspects of the canines at any time (Figure 
4.3A).   
 
There were no significant differences in the amount of IL-8 between any of the time 
points at the mesiobuccal and distopalatal second molar sites.  There was no 
statistically significant difference in the amount of IL-8 between the mesiobuccal and 
distopalatal aspects of the second molars at any time (Figure 4.3B).    
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Figure 4.3A&B – IL-8 levels (+/- SEM), for sites of tension (red) and 
compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
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4.4.1 Associations between clinical indices and IL-8 levels. 
  Correlations for each time point      
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns * ns ns ns 
Canine CS ns * ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
 
Table 4.3 Correlations between IL-8, plaque and bleeding indicies and the rate of 
tooth movement. TS=Tension Sites CS=Compression Sites *=significant, 
B=borderline significance, ns=no significance. 
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4.5 Tissue Necrosis Factor "  
Significant differences were found in TNF# levels at mesiobuccal sites between 
Baseline and T2 (P<0.05) and Baseline and T4 (P<0.01). No statistically significant 
differences were found in TNF# levels at any time for the distobuccal sites. (Figure 
4.4A) 
 
 There were no statistically significant differences in the amount of TNF# between the 
mesiobuccal and distopalatal aspects of the canines at any time studied (Figure 4.4A). 
 
There was a significant difference in the amount of TNF#  between Baseline and T1 
(P<0.05) and Baseline and T2 (P<0.01), at mesiobuccal second molar sites.  No 
statistically significant differences were found at distobuccal second molar sites. 
There was no statistically significant difference in the amount of TNF# between the 
mesiobuccal and distopalatal aspects of the second molars (Figure 4.4B).    
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Figure 4.4A&B – TNF" levels (mean +/- SEM), for sites of tension (red) and 
compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
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4.5.1 Associations between clinical indices and TNF" levels. 
  Correlations for each time point      
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns ns ns 
Canine CS ns * ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns * ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
 
Table 4.4 Correlations between TNF#, plaque and bleeding indicies and the rate 
of tooth movement. TS=Tension Sites CS=Compression Sites *=significant, 
B=borderline significance, ns=no significance. 
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4.6 Granulocyte-Macrophage Colony-Stimulating     
Factor 
 
No statistically significant differences were found in the levels of GM-CSF between 
any times at any sites. 
 
There were no statistically significant differences in the amount of GM-CSF between 
the mesiobuccal and distopalatal aspects of the canines at any time (Figure 4.5A). 
 
There was a significant difference in the amount of GM-CSF  between Baseline and 
T1 (P<0.05) at mesiobuccal second molar sites.  There were no significant differences 
in the amount of GM-CSF  between any time points at the distopalatal second molar 
sites.  There were no statistically significant differences in the amount of GM-CSF 
between the mesiobuccal and distopalatal aspects of the second molars at any time 
(Figure 4.5B).    
 
Chapter 4  Cytokine Results 
 89 
 
Figure 4.5A&B – GM-CSF levels (mean +/-SEM), for sites of tension (red) and 
compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
 
A 
B 
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4.6.1 Associations between clinical indices and GM-CSF levels. 
 
Table 4.5 Correlations between GM-CSF, plaque and bleeding indicies and the 
rate of tooth movement. TS=Tension Sites CS=Compression Sites *=significant, 
B=borderline significance, ns=no significance. 
 
  Correlations for each time point      
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns * ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
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4.7 Interferon #  
No significant differences were found for the levels of IFN! at either site at any  time.  
There were no statistically significant differences in the amount of IFN! between the 
mesiobuccal and distopalatal aspects of the canines at any time (Figure 4.6A). 
 
There were no significant differences in the amount of IFN! at any time at the 
mesiobuccal or distopalatal second molar sites.  There were no statistically significant 
differences in the amount of IFN! at the mesiobuccal and distopalatal aspects of the 
second molars at any time points (Figure 4.6B).    
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Figure 4.6A&B – IFN# levels (mean +/- SEM), for sites of tension (red) and 
compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
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4.7.1 Associations between clinical indices and IFN# levels. 
 
 
Table 4.6 Correlations between IFN#, plaque and bleeding indicies and the rate 
of tooth movement. TS=Tension Sites CS=Compression Sites *=significant, 
B=borderline significance, ns=no significance. 
  Correlations for each time point      
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns ns ns 
Canine CS ns * ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns * * ns ns 
            
Bleeding           
Canine TS * ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
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5.1 Introduction  
This chapter presents findings for tissue metabolites measured in GCF taken at all 
time points during the orthodontic treatment. Five tissue metabolites were assayed;  
MMP-9,  TIMP-1, TIMP-2, TIMP-3, TIMP-4.  However, TIMPs 3 and 4 were 
beneath the detection levels of the assays.  The three detectable compounds and their 
ratios will now be reported upon.  Correlations between metabolite levels and clinical 
measures were analysed using Spearmans Rank Correlations, unless otherwise stated. 
 
5.2 Matrix Metallopeptidase-9 
There were significant differences between the levels of MMP-9 expressed 
mesiobuccally to the upper canine, between time points; Baseline and T2 (p<0.01) 
and Baseline and T3 (P<0.05) (Figure 5.1A). There were also significant differences 
between the levels of MMP-9 expressed distopalatally to the upper canine, between 
Baseline and T3 (p<0.05) and Baseline and T4 (p<0.05) (Figure 5.1A).  Significant 
differences were found in MMP-9 levels around the second molars at the mesiobucal 
(compression) site from Baseline at T1 (P<0.05) and T2 (P<0.01) (Table 5.1B).   
 
There were no statistically significant differences in the amount of MMP-9 from the 
mesiobuccal and distopalatal aspects of the canines or second Molars at any time.   
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Figure 5.1A&B – MMP-9 levels (+/- SEM), for sites of tension (red) and 
compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
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5.2.1 Associations between clinical indices and MMP-9 levels. 
 
Table 5.1 Correlations between MMP-9, plaque and bleeding indicies and the 
rate of tooth movement. . TS=Tension Sites CS=Compression Sites *=significant, 
B=borderline significance, ns=no significance. 
 
  Correlations for each time point      
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns ns ns 
Canine CS * ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
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5.3 Tissue Inhibitor of Metalloproteinases-1 
There were significant differences between the levels of TIMP-1 expressed 
mesiobuccally to the upper canine, between time points Baseline and T2 (p<0.05), 
Baseline and T3 (P<0.01) and Baseline and T4 (P<0.001) (Figure 5.2A). There were 
also significant differences between the levels of TIMP-1 expressed distopalatally to 
the upper canine, between Baseline and T2 (p<0.05) (Figure 5.2A).  There was a 
significant difference between TIMP-1 levels at Baseline and T3 at the second molar 
mesiobuccal (compression site) (P<0.05) (Figure 5.2B). 
 
There were no statistically significant differences in the amount of TIMP-1 between 
the mesiobuccal and distopalatal aspects of the canines or second molars at any time.   
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Figure 5.2A&B – TIMP-1 levels (mean +/- SEM), for sites of tension (red) and 
compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
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5.3.1 Associations between clinical indices and TIMP-1 levels. 
 
Table 5.2 Correlations between TIMP-1, plaque and bleeding indicies and the 
rate of tooth movement. . TS=Tension Sites CS=Compression Sites *=significant, 
B=borderline significance, ns=no significance. 
 
  Correlations for each time point      
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns ns ns 
Canine CS ns * ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
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5.4 Tissue Inhibitor of Metalloproteinases-2 
There were significant differences between the levels of TIMP-2 expressed 
mesiobuccally to the upper canine, between time points Baseline and T2 (p<0.05), 
Baseline and T3 (P<0.01), Baseline and T4 (P<0.05) and T1 and T3 (P<0.05) (Figure 
5.3A). There were also significant differences between the levels of TIMP-2 
expressed distopalatally to the upper canine between Baseline and T3 (p<0.05) 
(Figure 5.3A).  There were no significant changes in TIMP-2 levels at the second 
molars. 
 
There were no significant differences in TIMP-2 expression between the mesiobuccal 
and distopalatal aspects of the canines or second molars at any of the time points 
(Figure 5.3B).  
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Figure 5.3A&B – TIMP-2 levels (mean +/- SEM), for sites of tension (red) and 
compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
B 
A 
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5.4.1 Associations between clinical indices and TIMP-2 levels. 
  Correlations for each time point     
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns ns * ns 
Canine CS ns * ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
 
Table 5.3 Correlations between TIMP-2, plaque and bleeding indicies and the 
rate of tooth movement. . TS=Tension Sites CS=Compression Sites *=significant, 
B=borderline significance, ns=no significance. 
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5.5 Ratio MMP-9 / TIMP-1 
There were no significant differences between the ratio of MMP-9/TIMP-1 expressed 
mesiobuccally or distopalatally to the upper canine or second molar, between any 
time points.  
 
There were no statistically significant differences in the ratio of MMP-9/TIMP-1 
between the mesiobuccal and distopalatal aspects of the canines or second molars at 
any time.   
 
Chapter 5  Tissue Metabolite Results 
 105 
 
Figure 5.4A&B – MMP-9/TIMP-1 levels (mean +/- SEM), for sites of tension 
(red) and compression (blue) from maxillary canines and second molars. Dotted 
lines represent mean values at baseline and parallel solid lines represent the SEM 
of the baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
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5.5.1 Associations between clinical indices and MMP-9/TIMP-1 
levels. 
  Correlations for each time point    
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns * ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
 
Table 5.4 Correlations between MMP-9/TIMP-1 ratio, plaque and bleeding 
indicies and the rate of tooth movement. . TS=Tension Sites CS=Compression 
Sites *=significant, B=borderline significance, ns=no significance. 
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5.6 Ratio MMP-9 / TIMP-2 
There were no significant differences between the ratio of MMP-9/TIMP-2 expressed 
mesiobuccally or distopalatally to the upper canine or second molar, at any time 
(Figures 5.5A and 5.5B). 
 
There were no significant differences in the ratio of MMP-9/TIMP-2 between the 
mesiobuccal and distopalatal aspects of the canines or second molars at any time.   
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Figure 5.5A&B – MMP-9/TIMP-2 levels (mean +/- SEM), for sites of tension 
(red) and compression (blue) from maxillary canines and second molars. Dotted 
lines represent mean values at baseline and parallel solid lines represent the SEM 
of the baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
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5.6.1 Associations between clinical indices and MMP-9/TIMP-2 
levels. 
  Correlations for each time point     
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns * ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
 
 
Table 5.5 Correlations between MMP-9/TIMP-2 ratio, plaque and bleeding 
indicies and the rate of tooth movement. . TS=Tension Sites CS=Compression 
Sites *=significant, B=borderline significance, ns=no significance. 
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6.1 Introduction  
This chapter presents findings for bone metabolites measured in GCF taken at all time 
points during the orthodontic treatment. OPG and RANKL were assayed and are 
reported together with their ratios.  Correlations between OPG and RANKL levels 
and clinical measures were analysed by Spearman Rank Correlations, unless 
otherwise stated. 
 
6.2 Osteoprotegerin 
There were no significant differences between the levels of OPG expressed 
mesiobuccally or distopalatally to the upper canine or at second molar sites between 
any time points (Figure 6.1A&B). 
 
There were no statistically significant differences in the amount of OPG between the 
mesiobuccal and distopalatal aspects of the canines or second molars at any time.   
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Figure 6.1A&B – OPG levels (mean +/- SEM), for sites of tension (red) and 
compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
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6.2.1 Associations between clinical indices and OPG levels. 
 
Table 6.1 Correlations between OPG, plaque and bleeding indicies and the rate 
of tooth movement. . TS=Tension Sites CS=Compression Sites *=significant, 
B=borderline significance, ns=no significance. 
 
  Correlations for each time point     
           
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns * ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns * ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
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6.3 Receptor Activator of Nuclear Factor Kappa-B  
Ligand 
There were no significant differences between the levels of RANKL mesiobuccally to 
the upper canine, between any of the time points. There was a significant difference 
between the levels of RANKL expressed distopalatally to the upper canine, between 
Baseline and T4 (p<0.05) (Figure 6.2A).   There were no significant changes in the 
levels of RANKL at either second molar site (Figure 6.2B). 
 
There were no statistically significant differences in the amount of RANKL between 
the mesiobuccal  and distopalatal  aspects of the canines or second molars at any time.   
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Figure 6.2A&B – RANKL levels (+/- SEM), for sites of tension (red) and 
compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
Chapter 6  Bone Metabolite Results 
 116 
6.3.1 Associations between clinical indices and RANKL levels. 
  Correlations for each time point     
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns * * 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns ns ns ns 
Canine CS ns ns * ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
 
Table 6.2 Correlations between RANKL, plaque and bleeding indicies and the 
rate of tooth movement. . TS=Tension Sites CS=Compression Sites *=significant, 
B=borderline significance, ns=no significance. 
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6.4 RANKL/OPG Ratio 
There were no significant differences between the RANKL/OPG ratio expressed 
mesiobuccally to the upper canine, between any time points.  There was a significant 
difference between the levels of RANKL/OPG expressed distopalatally to the upper 
canine between T2 and T4 only (p<0.05).  None of the changes at either second molar 
site were statistically different (Figure 6.3A). 
 
There were no statistically significant differences in the amount of RANKL/OPG 
ratio expressed at any time (Figure 6.3B). 
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Figure 6.3A&B – RANKL/OPG ratio (mean +/- SEM), for sites of tension (red) 
and compression (blue) from maxillary canines and second molars. Dotted lines 
represent mean values at baseline and parallel solid lines represent the SEM of the 
baseline values. Statistical analysis by Kruskal-Wallis: *p<0.05; **p<0.01; 
***p<0.001.  
A 
B 
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6.4.1 Associations between clinical indices and RANKL/OPG levels. 
  Correlations for each time point     
            
  Baseline T1 T2 T3 T4 
Plaque           
Canine TS ns ns ns * ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Bleeding           
Canine TS ns ns ns ns ns 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
Rate of Movement           
Canine TS ns ns ns ns * 
Canine CS ns ns ns ns ns 
Second molar TS ns ns ns ns ns 
Second molar CS ns ns ns ns ns 
            
 
Table 6.3 Correlations between RANKL/OPG ratio, plaque and bleeding indicies 
and the rate of tooth movement. . TS=Tension Sites CS=Compression Sites 
*=significant, B=borderline significance, ns=no significance. 
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7.1 Discussion 
 
This study is the first to measure a large number of inflammatory, tissue and bone 
metabolism biomarkers using GCF from teeth undergoing orthodontic tooth 
movement. The development of protein/cytokine arrays has allowed testing of more 
than one biomarker within a small GCF sample, and thus profile changes occurring 
within the tissues surrounding the tooth.   
 
In the present study three null hypotheses were tested; 1) There will be no change in 
the biomarker profile in GCF, 2) There will be no difference in the GCF biomarker 
profiles at compression and tension sites. 3) There will be no correlations between the 
various cytokines tested and the rate of tooth movement.  Each of these hypotheses 
will be commented on in turn. 
 
Previous studies that have recorded plaque and gingival health measurements have 
not reported them in detail (Yamaguchi et al., 2006; Giannopoulou et al., 2006).  
Unless high levels of oral hygiene are achieved prior to, and maintained during, 
treatment it is impossible to tell if the changes to the bio-markers are due to tooth 
movement or changes in oral hygiene and the resultant periodontal inflammation.  
 
This study demonstrated significant increases in GCF volume at both the tension and 
compression sites on canines during movement.  No differences in GCF volume were 
found between tension and compression sites and there were no differences between 
the GCF levels at the canines in comparison to the second molars.  These findings  
suggest that there was a systemic response caused by the appliance placement and 
tooth movement, since  a localised response would have lead to raised GCF around 
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the upper canines but unchanged GCF levels at the second molars which have no 
appliances or active forces acting upon them. 
 
No significant differences were seen in full mouth plaque scores at any time. This 
demonstrated no compromise in plaque removal due to appliance placement.  Neither 
did plaque levels increase when a distalising spring was placed, even though the 
springs harboured food particles.   
 
Plaque scores at tension sites were significantly greater at the canines than the second 
molars at all time points except baseline.  It is possible that this demonstrates that a 
combination of appliance placement and space opening mesial to the upper canine 
tooth may have encouraged food accumulation and hampered efficient plaque 
removal.  Alternatively as the canine was the tooth undergoing most tooth movement 
it may be that it was more uncomfortable to clean.  
 
Yamaguchi et al., (2006) found that Substance P and IL-1! were significantly 
increased in gingivae adjacent to teeth, which were orthodontically moved for up to 
72 hours after force application, but remained at baseline levels around the control 
teeth.  The forces applied to these teeth were probably not acting at their later 
sampling times, Substance P would have likely been increased at these time points 
also. Erdinc and Dincer (2004) suggested that from the results of their study that they 
felt that the perception of pain may be related to Substance P release.  Hence teeth 
undergoing active movement are associated with pain.  Substance P was not measured 
in the present study however other studies have also related increased IL-1! levels 
with increased pain perception (Giannopoulou  et al., 2006). IL-1! was shown to be 
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increased in canine tension sites in the present study at all time points and so that 
pain/discomfort may be the reason for increased plaque accumulation at these sites 
relative to the second molar. 
 
Bleeding indices remained constant except for the decrease seen between baseline and 
4 hours after a distalising force was applied, indicating that periodontal inflammation 
was less once the spring had been applied and then returned back to normal levels for 
the subject.  Or perhaps that the forces created caused a relative tissue ischemia due to 
the distortion of periodontal cappiliaries and blood vessels.  
 
Correlations between plaque scores and GCF levels were significant at both tension 
and compression canine sites 3 months after appliance placement.  This suggests that 
before the distalising force was applied to the canine, increases in GCF associated 
with these teeth were due to inflammation from insufficient plaque removal. 
 
Bleeding indices at tension sites were higher at the canines than the second molars 
after 4 hours and 7 days of distalising force. It is likely that active force causes more 
periodontal inflammation than passive force at a tension site. 
 
Analysis of the amount of tooth movement showed that teeth had begun to move 4 
hours after a distalising force had been applied and that they had moved a 
significantly greater distances 42 days after force application. Analysis of speed of 
movement demonstrated that 4hrs after the application of a distalising force tooth 
movement was fastest. It then decelerated over 7 and 42 days, perhaps illustrating that 
at 4 hours the tooth was in the first phase of tooth movement in displacement 
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(Burstone, 1962). During the second phase of tooth movement which is a lag period 
with relatively low rates of tooth displacement. Hyalinization occurs in the PDL in 
areas of compression and no further tooth movement can happen until necrotic tissue 
is removed. 
 
Analysis of cytokines around the canines revealed significant increase in IL-1!, IL-8, 
and TNF" in comparison to baseline levels at tension sites once a distalising force 
was active. 4 hours after the distalising force was placed IL-1! levels peaked at 
canine tension and compression sites and IL-8 levels peaked at canine tension sites.  
This suggests that these levels rose quickly in response to the orthodontic force as part 
of an acute reaction.  IL-1! attracts leukocytes and stimulating fibroblasts and 
endothelial cells osteoclasts which promote bone resorption and inhibit bone 
formation.  IL-8 is thought to be a trigger factor for bone remodelling TNF" which 
promotes bone resorption, it is therefore likely that both should peak at tension sites.  
IL-8 also regulates the influx of leukocytes to the site of inflammation. Whether this 
reaction is inflammatory or not is a subject for debate. Meikle (2006) suggested that 
tooth movement did not meet three of the four classical criteria of inflammation 
(redness, heat, swelling and pain), only pain was present.  He suggested that tooth 
movement was best regarded as an exaggerated form of normal physiological 
turnover combined with foci of tissue repair.  TNF alpha levels peaked 42 days after a 
distalising force was applied, perhaps revealing a more chronic inflammatory 
response. IL6 showed an increase at the tension site 3 months into appliance treatment 
and 42 days after the distalising force had been applied, suggesting that it was 
released more slowly and not as a response to acute inflammation. GM-CSF and IFN" 
levels remained constant at canine sites. TNF" and GM-CSF levels rose at the 
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compression sites on the second molars 3 months after appliance placement.  Four 
hours after the distalising force was applied the TNF" values rose again. All other 
cytokine levels tested at the second molars remained constant. Increases in cytokines 
recorded at the control second molar teeth, may imply that the application of force 
affects the whole mouth, though this change was more transient than that seen at the 
canines.  
 
At Baseline and three months into treatment IL-1! , IL-8, TNF#, IFN" levels all 
showed associations with plaque levels at canine sites.  There were no significant 
correlations between plaque and bleeding indices and the levels of IL-1! , IL-8 or 
TNF# once the distalising force had been applied. This suggests subsequent changes 
in IL-1! , IL-8 and TNF# were due to orthodontic force and tooth movement. IL-6 
and GM-CSF were not associated with plaque and bleeding scores at any point in the 
study.  This suggests fluctuations in cytokine levels once a distalising force was 
applied were due to inflammation resulting from orthodontic forces.   
 
This study agrees with clinical findings from other studies which have shown that IL-
1! and TNF# are all elevated in gingival crevicular fluid collected from patients 
during the early phases of orthodontic tooth movement (Grieve et al 1994 ; Lowney et 
al 1995 ; Uematsu et al. 1996). 
 
Dudic et al (2006), found that the GCF levels of IL-1!, SP, and PGE2 in 
orthodontically moved teeth were significantly higher than for the control teeth at 
both tension and compression sides throughout force application. The increase, 
relative to baseline values, was generally higher in tension sides.  They also found 
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that although biomarker patterns were different at tension and compression sites, with 
generally higher values of cytokines at tension site, they were not significantly raised.  
The present findings support this view. 
 
Tissue metabolites showed similarities to cytokines with MMP-9, TIMP-1 and TIMP-
2 expressed more at canine tension sites following application of distalising force, 
with peaks at 7 days for TIMP-1 and 42 days for TIMP-2. MMP-9 was low after 7 
days.  Increases in MMP-9 occurred 7 days after force application at the compression 
sites.   Initially it seems that the levels of all bone metabolites increased in response to 
the orthodontic distalising force.  But that by 7 days the TIMPs 1 and 2 remained high 
at tension sites, whereas MMP-9 levels dropped at the tension sites and increased at 
the compression sites.  It is thus likely that new bone formation was at progress in the 
tension sites by this time. The higher levels of TIMPs would have inhibited the 
release of MMP-9, reducing its level so that boney resorption was occurring at 
compression sites. The ratios of MMP-9 to TIMP-1 and TIMP-2 did not produce 
significant conclusions. 
 
There were no correlations between increases in plaque and bleeding scores and any 
tissue metabolites once a distalising force was applied.   It can thus be deduced that 
changes in biomarker levels were due to the distalising force and resultant tooth 
movement. 
 
Regarding the bone metabolites, none of the changes in OPG levels were significant.  
However RANKL levels were significantly higher after 42 days at the canine 
compression sites.  Also the ratio of OPG to RANKL was significantly different after 
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42 days.  This suggests that the OPG RANKL interaction occurs later on in tooth 
movement.  There were no correlations with plaque and bleeding scores at 
compression sites so these changes are most likely be a consequence of applied force 
and tooth movement. Kanzaki et al. (2002) found that culture media from compressed 
PDL fibroblasts stimulated osteoclastogenesis in peripheral blood mononuclear cell 
cultures and that RANKL mRNA expression was upregulated in the cells. OPG 
expression in contrast remained unchanged as was found in this study. Kawasaki et al, 
(2006) discussed the differences between adult and juveniles for the expression of 
OPG and RANKL in GCF.  The amount of tooth movement for juveniles was larger 
than for adults after 168 hours (7 days). After 24 hours RANKL levels were increased 
and those of OPG decreased in GCF samples from the compression side during 
orthodontic tooth movement in both juveniles and adults. The RANKL/OPG ratio in 
GCF from adult patients was lower than that in the juvenile samples perhaps 
explaining why tooth movement is slower in adults. 
 
The ratio of OPG to RANKL around second molar compression sites was similar to 
that at canine compression sites, suggesting that bony resorption was occurring at 
both of these sites simultaneously.  
 
Yamaguchi et al. (2006) reported on associations between increases in RANKL 
expression in compressed periodontal ligament cells and root resorption.  Compressed 
PDL cells obtained from patients demonstrating severe external apical root resorption 
produced large amounts of RANKL, small amounts of OPG and stimulated osteoclast 
formation. A mini review of the topic Tyrovola et al. (2008) also described a link 
between RANKL levels, osteoclastic activation and root resorption. If an optimal 
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RANKL level could be targeted it might be possible to create tooth movement 
without causing resorption.  
 
Increases in TNF#, GM-CSF, IL-1! and IL-8 at the canines were correlated to speed 
of movement, indicating a rapid inflammatory response to applied force. Tissue and 
bone metabolism biomarkers followed different patterns. MMP-9, TIMP-2 and TIMP-
1 correlated with speed of movement 4 hours after application of a distilasing force. 
However, MMP-9 levels continued to increase at sites of compression and TIMP-1 
levels continued to increase at sites of tension 7 days after force. These changes in 
MMP-9 would be consistent with a need to decrease the density of soft tissue under 
compression. Bone metabolism biomarkers were not significantly correlated with 
speed of movement; however the greatest changes in OPG levels were seen within 4 
hours of force application. RANKL increased at 42 days after application of a 
distilising force. This could be the start of Phase 3 of tooth movement, where the 
increase in RANKL at sites of compression could indicate that activation of 
osteoclasts and bone resorption has begun.  
 
The present study subjects were divided into 3 groups depending on their overall rate 
of tooth movement.  Biomarker profiles were then compared for each of the groups to 
see if there were any obvious differences between fast movers, medium movers and 
slow movers.  However, no statistically significant differences were found and only 
IL-1!  showed a clear pattern with levels being highest in fast movers at all times and 
lowest in slow movers.  
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The present study has provided greater insight into tooth movement and the biological 
response of the surrounding tissues to this movement.  However the group size was 
insufficient to give the study enough power to demonstrate possible significant 
differences.  Post Hoc power analysis suggests that a sample size greater than 120 
patients would be required, and the subject warrants further.  It would also be 
interesting to add an additional time point at 84 days to look at the changes occurring 
once the tooth is in Stage 3 of orthodontic tooth movement (Burstone, 1962).  
 
Much of the recent research into tooth movement has looked at ways to reduce the lag 
phase of tooth movement, when hyalinisation occurs.  Studies have looked at 
minimising hyalinisation by examining the amount and duration of force on the teeth.  
It would be useful to look at a profile of cytokines in subjects receiving differing 
amounts of force and their durations. 
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8.1 Conclusions 
 
This study investigated the effects of orthodontic tooth movement on the 
periodontium by analysing cytokine, tissue and bone metabolite levels within GCF. 
As plaque and bleeding scores remained constant after force application, it is likely 
that biomarker changes in the periodontium most likely resulted from orthodontic 
forces. 
The null hypotheses being tested in this study were that, when an orthodontic force 
applied to a tooth 
 
1) There will be no change in the biomarker profile in GCF.   
This was disproved and this null hypothesis is rejected.  There were significant 
changes in the profile of several biomarkers at various times which were consistant 
with tissue remodelling. 
 
2) There will be no difference in the GCF biomarker profiles at the compression 
and tension sites.   
Although differences were seen between tension and compression sites, none were 
statistically significant.  It is likely that a greater number of subjects are needed to 
prove statistical significance between sites.  Thus this hypothesis stands. 
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3) There will be no correlations between the various cytokines tested and the rate of 
tooth movement.   
This was also disproved by increases of TNF!, GM-CSF, IL-1" and IL-8 at the 
canines, which correlated with the rate of tooth movement. MMP-9, TIMP-2 and 
TIMP-1 levels increased in line with speed of movement 4 hours after application of 
force. 
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Participant Information Sheet 
 Orthodontic tooth movement 
Version 4.0 (18
th
 June 2008) 
 
Assessment of changes in gingival fluid biomarkers during orthodontic tooth 
movement 
 
You are being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it will 
involve.  Please take time to read the following information carefully and discuss it 
with your parents and others if you wish.  Ask us if there is anything that is not clear 
or if you would like more information.  Take time to decide whether or not you wish 
to take part.  Thank you for reading this. 
 
What is the purpose of the study? 
By measuring the forces applied to a tooth and the concentration of certain chemicals 
released by the tissues around a tooth, this study aims to assess whether the levels of 
such chemicals change when different forces are applied.  This study will help to 
create a better understanding of the bone processes that take place when a force is 
applied to a tooth. It is hoped that it will ultimately help to identify those patients 
whose teeth will move faster or slower, so that treatment planning may be improved 
in the future to improve results for individual patients.                                                                         
                                                             
 
 
 Why have I been chosen to take part in the study? 
You have been chosen to take part in the study because you are a patient aged 12-16 
years, with good general health and are about to undergo a course of treatment with 
fixed braces. 
 
 
 
 
Do I have to take part in the study? 
It is up to you to decide whether or not to take part.  If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are still free to stop at any time and without giving a 
reason.  A decision to stop at any time, or a decision not to take part, will not affect 
the care you receive. 
 
What will happen to me if I take part? 
If you decide to take part in this study you will be treated in exactly the same manner 
as all our patients and will receive your treatment as normal but will be asked to 
attend the hospital for one long visit and one extra appointment to enable some 
samples to be taken from you and samples will also be taken at four of your routine 
appointments. Also you will have impressions taken of your teeth as well as gum 
health and plaque measurements at every appointment when samples are taken. 
 
You will not be eligible to take part in the study if-  
 
! You are a smoker. 
! Have poor oral hygiene 
! Signs of significant gum disease. 
! Evidence of bone loss around the teeth on xrays. 
! Have taken a courses of anti-inflammatory's or antimicrobial medicines within 
1 month prior to the study. 
 
 
 
 
 What do I have to do? 
At your treatment planning appointment (baseline) the study will be discussed, you 
may ask any questions that you need to and your consent will be obtained and a 
medical history taken.  Your gum health will be assessed and the amount of plaque on 
your teeth will be measured. Paper strips will be used to collect fluid from around 
your teeth (called gingival crevicular fluid or GCF) this is painless and you will not 
feel the sample collection.  Three months later the samples will be taken again and a 
spring will be placed to help to close the spaces where teeth have been taken out (as 
per normal) your gum health and plaque levels will again be assessed and an 
impression taken of your top teeth. Four hours later the samples will be repeated, 
together with gum health, plaque levels and an impression.    Four days later you will 
need to attend an extra visit for samples to be taken, your gum health and plaque 
levels will be assessed and an impression of the top teeth taken.  Five weeks later at 
your routine brace adjustment appointment more samples will be taken, gum health 
and plaque levels will be assessed and an impression of the top teeth taken.   
Treatment will then continue as normal. 
 
Will my taking part in the study be confidential? 
You will be allocated a study number, so that your name will not be disclosed to 
anyone except the people treating you.  Your name will not be identified with the data 
collected other than by a code.  If you wish to know your personal results these can be 
shared with you after the study is complete. You will have a dedicated team looking 
after you who will answer any questions you have at any stage. 
 
Are there any side effects of the treatment? 
You will be receiving no additional treatment as part of the study. There are no side 
effects involved in giving the samples as previously discussed. 
  
 
What are the possible disadvantages and risks of taking part? 
There are no disadvantages to taking part, you will have long visit and one extra visit 
of about 10 minutes and you will need the gum fluid samples taken at this visit.  At 
the longer visit you are free to leave the hospital after the morning part of your 
appointment, but we need you to return 4 hours later for the afternoon part. 
 
What are the possible benefits of taking part? 
You will get the chance to have your brace checked at the additional appointment, 
which may help to address any problems or concerns.  Also patients in the study will 
have their oral hygiene levels very closely monitored, which will minimise their risk 
of developing early decay around the brace/gum disease. 
 
What if new information becomes available? 
If new information becomes available, you will be told at your next visit. 
 
What happens when the research study stops? 
At the end of the study, you will return to normal treatment. 
 
 
What if something goes wrong? 
You are only providing gum fluid samples, so nothing will go wrong with this aspect 
of the study.  However, if you have any worries or concerns or problems a member of 
the study team will be available to discuss these with you.  If you wish to make a 
complaint you should contact Professor P Lumley by writing to the Birmingham 
Dental Hospital, St Chad’s Queensway, B4 6NN or calling 0121 236 8611. 
 
Who is organising and funding the research? 
This study is one that we have designed and led at the Dental Hospital. 
 
What about my travel costs for the additional visit? 
If you request re-imbursement of reasonable travel costs for the additional visit this 
will be provided in cash upon presentation of receipts.  Please ask the study clinician 
and they will arrange this for you. 
 
Who has reviewed this study? 
The study has been reviewed by Coventry Research Ethics Committee. 
 
Contact for further information? 
If you need further information please phone 0121 237 2735 and ask to speak to Jay 
Wilson who is managing the study.
Study Flow Chart 
 
 
Patient presents to the Birmingham dental hospital to start fixed brace treatment.   
Patient invited to join the study. Study 
explained, questions answered, information sheet 
and consent form given to patient.  Tooth 
cleaning and gum health assessed. 
 
Samples collected at treatment planning 
appointment. 
Brace fitted. 
 
Coil placed on brace and samples taken 
Samples taken 
Samples taken 
Routine appointment: final samples taken 
 
Routine treatment.  Treatment will continue as normal as if the 
patient had not been involved in a study. 
 
Patient not included in 
study. 
3 Months later 
4 Hours later 
4 Days later 
38 Days later 
Patient Declines or Does 
not meet criteria 
Study Ends 
Extra 
Visit 
Longer 
Visit 
Patient recruited into 
study 
  
 
 
Participant Consent Sheet  
Version 4.0 (18
th
 June 2008) 
 
Assessment of changes in gingival fluid biomarkers during orthodontic tooth 
movement 
 
 
Consent Statement: 
I have read the information sheet (version 4.0 dated 18
th
 June 2008) and been given 
the opportunity to ask any questions I wished to ask.  I understand what is involved in 
the project and I agree to take part in the study.  I understand that the study team will 
need to access my treatment notes and that anonymous data will need to be analysed 
by members of the study team.   I understand that my identity will be confidential to 
the study team alone and that I may withdraw from the study at any stage, without 
detriment to my treatment.   
 
 
 
 
Subject signature & date 
 
 
 
Subject Name (please print) 
 
 
 
Name & Signature & date of team member taking consent  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Parent Information Sheet  
 Orthodontic tooth movement 
Version 4.0 (18
Th
 June 2008) 
 
Assessment of changes in gingival fluid biomarkers during orthodontic tooth 
movement 
 
Your child is being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it will 
involve.  Please take time to read the following information carefully and discuss it 
with others if you wish.  Ask us if there is anything that is not clear or if you would 
like more information.  Take time to decide whether or not you wish to take part.  
Thank you for reading this. 
 
What is the purpose of the study? 
By measuring the forces applied to a tooth and the concentration of certain chemicals 
released by the tissues around a tooth, this study aims to assess whether the levels of 
such chemicals change when different forces are applied.  This study will help to 
create a better understanding of the biological processes that take place when a force 
is applied to a tooth. It is hoped that it will ultimately help to identify those patients 
whose teeth will move faster or slower, so that treatment planning may be improved 
in the future to optimise results for individual patients.  
 
Why has my chid been chosen to take part in the study? 
Your child has been chosen to take part in the study because he/she is a patient aged 
12-16 years, with good general health and is about to undergo a course of fixed brace 
treatment. 
 
Does my child have to take part in the study? 
It is up to you and your child to decide whether or not to take part.  If you do decide 
to take part you will be given this information sheet to keep and both be asked to sign 
a consent form. If you decide to take part you are still free to withdraw at any time 
and without giving a reason.  A decision to withdraw at any time, or a decision not to 
take part, will not affect the standard of care received by your child. 
 
What will happen to my child if we take part? 
If you decide to take part in this study your child will be treated in exactly the same 
manner as all our patients and will receive their treatment as normal but will be asked 
to attend the hospital for one long visit and one extra appointment to enable some 
samples to be taken, samples will also be taken at four routine appointments. Also 
impressions will be taken of your child’s teeth as well as gum health and plaque 
measurements at every appointment when samples are taken. 
 Your child will not be eligible to take part in the study if-  
 
! They are a smoker. 
! Have poor oral hygiene 
! Signs of signifficant gum disease. 
! Evidence of bone loss around the teeth on xrays. 
! Have taken a course of anti-inflammatory's or antimicrobial medicines within 
1 month prior to the study. 
 
 
What do we have to do? 
At the treatment planning appointment (baseline) the study will be discussed, you 
may ask any questions that you need to and your consent will be obtained together 
with your child’s  and a medical history taken.  Gum health will be assessed and the 
amount of plaque on your child’s teeth will be measured. Paper strips will be used to 
collect fluid from around the teeth (called gingival crevicular fluid or GCF) this is 
painless and your child will not feel the sample collection.  Three months later the 
samples will be taken again and a spring will be placed to help to close the spaces 
where teeth have been taken out (as per normal) gum health and plaque levels will 
again be assessed and an impression taken of the top teeth.  Four hours later the 
samples will be repeated, together with gum health, plaque levels and an impression.   
Four days later you will need to attend an extra visit for samples to be taken, gum 
health and plaque levels will be assessed and an impression of the top teeth taken.  
Five weeks later at the routine brace adjustment appointment more samples will be 
taken, gum health and plaque levels will be assessed and an impression of the top 
teeth taken.   Treatment will then continue as normal. 
 
Will our taking part in the study be confidential? 
Your child will be allocated a study number, so that their name will not be disclosed 
to anyone except the clinical people treating you.  Their name will not be identified 
with the data collected other than by a code.  If you wish to know your child’s 
personal results these can be shared with you after the study is complete. You will 
have a dedicated team looking after you who will answer any questions you have at 
any stage. 
 
Are there any side effects of the treatment? 
Your child will be receiving no additional treatment as part of the study. There are no 
side effects involved in giving the samples as previously discussed. 
  
What are the possible disadvantages and risks of taking part? 
There are no disadvantages to taking part, you will have one long visit and one extra 
visit of about 10 minutes, you will need the gum fluid samples taken at this visit. At 
the longer visit you and your child are free to leave the hospital after the morning part 
of your appointment, but we need you to return 4 hours later for the afternoon part. 
 
 
What are the possible benefits of taking part? 
Your chid will get the chance to have their brace checked at the additional 
appointment, which may help to address any problems or concerns.  Also patients in 
the study will have their oral hygiene levels very closely monitored, which will 
minimise their risk of developing early decay around the brace/gum disease. 
 
What if new information becomes available? 
If new information becomes available, you will be informed of this at your next visit. 
 
What happens when the research study stops? 
At the end of the study, your child will enter a normal review process and any further 
treatment needed will be arranged with a member of staff as is normal practice. 
 
What if something goes wrong? 
Your child is only providing gum fluid samples, so nothing will go wrong with this 
aspect of the study.  However, if you have any worries or concerns or problems a 
member of the study team will be available to discuss these with you.  If your child is 
harmed due to someone’s negligence, then you may have grounds for a legal action 
but you may have to pay for it.  If you wish to make a complaint you should contact 
Professor P Lumley by writing to the Birmingham Dental Hospital, St Chad’s 
Queensway, B4 6NN or calling 0121 236 8611. 
 
Who is organising and funding the research? 
This study is one that we have designed and led at the Dental Hospital. 
 
What about my travel costs for the additional visit? 
If you request re-imbursement of reasonable travel costs for the additional visit this 
will be provided in cash upon presentation of receipts.  Please ask the study clinician 
and they will arrange this for you. 
 
Who has reviewed this study? 
The study has been reviewed by Coventry Research Ethics Committee. 
 
Contact for further information? 
If you need further information please phone 0121 237 2735 and ask to speak to Jay 
Wilson who is managing the study.
  
 
 
 
 
 
 
 
 
Parent Consent Sheet  
Version 4.0 (18
th
 June 2008) 
 
 
Assessment of changes in gingival fluid biomarkers during orthodontic tooth 
movement 
 
 
 
Childs Name:…………………………………………………………………………. 
 
Consent Statement: 
I have read the information sheet (version 4.0 dated 18
th
 June 2008), and been given 
the opportunity to ask any questions I wished to ask.  I understand what is involved in 
the project and I agree for my child to take part in the study.  I understand that the 
study team will need to access my child’s treatment notes and that anonymous data 
will need to be analysed by members of the study team.   I understand that my child’s 
identity will be confidential to the study team alone and that we may withdraw from 
the study at any stage, without detriment to treatment.   
 
 
 
Guardian signature 
 
 
Guardians Name (Please print) & Date 
 
 
 
 
Name & Signature & date of team member taking consent  
 
 
Appendix B 1 
Periotron 8000 calibration. 
 
Raw data 
 
Volume 
(ul)   
Periotron 
Reading   Mean 
  1 2 3   
0.02 4 5 5 4.67 
0.04 9 10 10 9.67 
0.06 15 16 16 15.67 
0.08 19 19 19 19.00 
0.1 23 24 23 23.33 
0.12 29 32 30 30.33 
0.14 34 35 36 35.00 
0.16 37 38 39 38.00 
0.18 40 39 41 40.00 
0.2 43 42 44 43.00 
0.22 50 51 52 51.00 
0.24 55 55 55 55.00 
0.26 57 58 57 57.33 
0.28 60 62 61 61.00 
0.3 64 63 64 63.67 
0.32 65 66 66 65.67 
0.34 68 68 69 68.33 
0.36 72 72 73 72.33 
0.38 77 78 78 77.67 
0.4 80 81 80 80.33 
0.42 83 83 83 83.00 
0.44 86 85 85 85.33 
0.46 88 89 88 88.33 
0.48 95 96 95 95.33 
0.5 98 97 97 97.33 
0.6 107 110 109 108.67 
0.7 119 118 118 118.33 
0.8 123 124 125 124.00 
0.9 139 137 137 137.67 
1 146 145 146 145.67 
1.1 152 151 150 151.00 
1.2 159 158 156 157.67 
1.3 164 163 161 162.67 
1.4 169 168 167 168.00 
1.5 171 172 169 170.67 
 
 
 
 
 
 
 
 
 Appendix B 2 
 
Periotron values for set fluid volumes calculated from the previous equation. 
 
Volume Periotron value  Volume Periotron value  Volume Periotron value 
0.004 1  0.277 60  0.707 119 
0.008 2  0.282 61  0.717 120 
0.012 3  0.288 62  0.727 121 
0.016 4  0.294 63  0.737 122 
0.02 5  0.299 64  0.747 123 
0.024 6  0.305 65  0.757 124 
0.028 7  0.311 66  0.768 125 
0.032 8  0.317 67  0.778 126 
0.036 9  0.323 68  0.788 127 
0.04 10  0.329 69  0.799 128 
0.044 11  0.335 70  0.81 129 
0.048 12  0.341 71  0.821 130 
0.052 13  0.347 72  0.832 131 
0.056 14  0.353 73  0.844 132 
0.06 15  0.359 74  0.856 133 
0.065 16  0.366 75  0.867 134 
0.069 17  0.372 76  0.879 135 
0.073 18  0.378 77  0.89 136 
0.077 19  0.385 78  0.903 137 
0.082 20  0.391 79  0.915 138 
0.086 21  0.398 80  0.927 139 
0.09 22  0.404 81  0.94 140 
0.095 23  0.411 82  0.953 141 
0.099 24  0.417 83  0.966 142 
0.103 25  0.424 84  0.979 143 
0.108 26  0.431 85  0.992 144 
0.112 27  0.438 86  1.006 145 
0.117 28  0.445 87  1.02 146 
0.121 29  0.452 88  1.034 147 
0.126 30  0.459 89  1.048 148 
0.13 31  0.466 90  1.063 149 
0.135 32  0.473 91  1.078 150 
0.14 33  0.48 92  1.093 151 
0.144 34  0.488 93  1.108 152 
0.149 35  0.495 94  1.124 153 
0.154 36  0.503 95  1.14 154 
0.158 37  0.511 96  1.157 155 
0.163 38  0.518 97  1.173 156 
0.168 39  0.525 98  1.19 157 
0.173 40  0.533 99  1.208 158 
0.178 41  0.541 100  1.226 159 
0.183 42  0.549 101  1.244 160 
0.188 43  0.557 102  1.263 161 
0.192 44  0.565 103  1.283 162 
0.197 45  0.573 104  1.303 163 
0.202 46  0.581 105  1.323 164 
0.208 47  0.59 106  1.345 165 
0.213 48  0.599 107  1.368 166 
0.218 49  0.607 108  1.391 167 
0.223 50  0.615 109  1.416 168 
0.228 51  0.624 110  1.442 169 
0.233 52  0.633 111  1.47 170 
0.239 53  0.642 112  1.499 171 
0.244 54  0.651 113  1.532 172 
0.249 55  0.66 114  1.569 173 
0.255 56  0.669 115  1.614 174 
0.26 57  0.679 116  1.673 175 
0.266 58  0.688 117    
0.271 59  0.698 118    
 
